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ABSTRACT 
 
Deciphering Active Estrogen-Degrading Microorganisms in Bioreactors. (August 2009) 
Hyung Keun Roh, B.E., Korea University; 
M.E., Texas A&M University 
Chair of Advisory Committee: Dr. Kung-Hui Chu 
 
 Estrogens are a group of endocrine disrupting compounds capable of causing 
abnormalities in the reproductive systems of the wildlife.  Wastewater is a major source 
of environmental estrogens, in part due to incomplete removal of estrogens in biological 
wastewater treatment processes.  This dissertation investigated factors affecting estrogen 
biodegradation in bioreactors.  Specifically, research efforts were placed on 
characterization of several bacterial estrogen degraders (model strains: Aminobacter 
strains KC6 and KC7, and a Sphingomonas strain KC8) and examination of the effects 
of operating parameters on estrogen removal and estrogen-degrading microbial 
community structure. 
Sphingomonas strain KC8 can use 17β-estradiol as a sole carbon source, 
suggesting that estrogen degradation by KC8 is a growth-linked, metabolic reaction; 
however, estrogen degradation by strains KC6 and KC7 might be a non-growth linked, 
cometabolic reaction. One important finding was that strain KC8 can also degrade and 
further utilize testosterone as a growth substrate.  Strain KC8 was characterized in terms 
of its utilization kinetics toward estrogens and testosterone with the results that showed 
 iv
relatively smaller kinetic parameters than the typical values for heterotrophs in activated 
sludge.  Strain KC8 can also grow on other organic constituents (glucose, succinate, and 
acetate).  Strain KC8 retained its ability to degrade both 17β-estradiol and estrone (after 
15 d of growth on a complex nutrient medium without 17β-estradiol). 
Effective removals (>98.7 %) of 17β-estradiol with no significant differences 
were observed in sequencing batch reactors (SBRs) under three solid retention times 
(SRTs of 5, 10, 20 d).  The population ratios of known estrogen degraders (strains KC8 
and ammonia-oxidizing bacteria (AOB)) and amoA gene (associated with ammonia 
oxidation) to total bacteria decreased as SRT increased in SBRs.  These observations 
correspond to the decreasing percentages of 17β-estradiol biodegraded in SBR when 
SRT increased from 5 to 20 d, when the sorption of 17β-estradiol onto biomass was 
considered.  Real-time terminal restriction fragment length polymorphism showed that 
more ribotypes were observed in SBR-20d than SBR-5d.  The species evenness (E) in 
microbial community structures in SBRs was not affected by SRT.  However, diversity 
indices (Shannon-Weaver diversity index (H) and the reciprocal of Simpson’s index 
(1/D)) suggest that longer SRTs might lead to a more diverse microbial community 
structure. 
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1. INTRODUCTION 
 
1.1  Introduction 
Endocrine disrupting compounds (EDCs) in water environments have raised a 
great public concern in recent years.  The exposure to EDCs like estrogens is known to 
cause reproductive and sexual disruption in aquatic wildlife (1-4). For example, 
feminization of male fish was observed after exposure to estrogenic compounds in 
treated wastewater (5-8).  Baronti et al. (9) and Purdom et al. (10) reported that even a 
few ng/L of estrogens can provoke reproductive disruption in riverine fish.  Despite the 
controversial viewpoints of human health effects, previous studies reported that exposure 
to estrogens is linked to the development of breast and testicular cancers (11, 12).  The 
US Environmental Protection Agency (EPA) began an EDC screening program in 1996 
(13, 14).  Pesticides and other substances are currently screened for their potential effects 
on the endocrine system (13).  Estrogens, produced by humans and animals or used for 
personal care like hormone therapy, are excreted in urine and feces that enter into 
sewage for wastewater treatment (15, 16).  Estrogens remaining in the effluent are 
subsequently released into the environment via effluent discharge (17).   Estrogens have 
been detected in the effluent of wastewater treatment plants (WWTPs), in rivers, and 
even in drinking water (18, 19).  Estrogens can be removed via the activated sludge 
process in wastewater treatment plants (19-21).  As such, the runoff from sewage/ 
biosolids applications for agriculture is another source of environmental estrogens (22). 
____________ 
This dissertation follows the style of Environmental Science & Technology. 
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 While many studies have been focused on advanced chemical and physical 
processes to remove estrogens from wastewater, studies on the biodegradation of 
estrogens and the microorganisms responsible for their degradation are few.   Layton et 
al. (21) reported that biosolids from municipal WWTPs mineralized 70-80 % of 
amended 17β-estradiol into carbon dioxide within 24 h, suggesting that biodegradation 
would be an important removal mechanism for estrogen during wastewater treatment.  
Later, several estrogen-degrading bacteria, including Nitrosomonas europaea, 
Novosphingobium tardaugens (ARI-1), Rhodococcus species, Achromobacter species, 
and Ralstonia species have been isolated from activated sludge (23-26).   More recently, 
Yu et al. (27) isolated fourteen estrogen-degrading isolates (strains KC1 through KC14) 
from activated sludge.  Among the fourteen isolates, only three strains (Aminobacter 
strains KC6 and KC7, and Sphingomonas strain KC8 (refered as “KC6”, “KC7”, and 
“KC8”, respectively, hereafter)) could degrade both 17β-estradiol and estrone.  Strain 
KC8 could degrade 17β-estradiol to non-estrogenic metabolites and/or end products.  
However, these three strains have not been fully characterized, and the potential of their 
application for enhanced estrogen removal in engineered bioreactors has not been 
addressed.  In this study, a series of experiments were conducted to characterize 
estrogen-degrading microorganisms and to examine their potential for improving 
estrogen removal in bioreactors. 
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1.2  Hypothesis, Goal, and Objectives 
The overall hypothesis of this research is that enhanced estrogen degradation 
can be achieved by promoting the growth of estrogen degraders in engineered 
bioreactors. The goal of this research is to better understand factors affecting 
biodegradation of estrogens in engineered systems, as the first step in developing 
advanced biological treatment strategies for enhanced estrogen removal in wastewater 
treatment plants. The hypothesis was tested through two specific objectives: 
 
1. Characterization of a Sphingomonas strain KC8 (27) focusing on (i) 
growth; (ii) degradation kinetics; (iii) its ability to utilize macro- and 
micro-pollutants that co-exist in wastewater; and (iv) investigation of 
other factors, such as complex nutrients, on its estrogen degradability.  
2. Investigation of factors affecting estrogen removal in bioreactors.  
Particularly the effects of solids retention time (an important operating 
parameter for engineered bioreactors) on estrogen-degraders and their 
performance in estrogen removal were studied. 
 
Strains KC6, KC7, and KC8, Novosphingobium tardaugens (ARI-1), and 
ammonia-oxidizing bacteria were used as model microorganisms in this study.  These 
strains were chosen because of their degradation ability toward estrogens.    
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1.3 Dissertation Overview 
There are seven sections in this dissertation.  The literature review for this 
research is in Section 2.  Materials and methods used in this study are described in 
Section 3.  The ability of strains KC6, KC7, and KC8 to use estrogens as a growth 
substrate and the presence of nonspecific oxygenase enzymes are addressed in Section 4; 
the results of this section have been published in a peer-reviewed journal, Environmental 
Science & Technology. Section 5 describes characteristics of strain KC8, including its 
degradation kinetics of estrogen-testosterone and its ability to use common pollutants in 
wastewater.  The effects of complex nutrients on estrogen degradability of strain KC8 
were also examined. Section 6 describes the effects of solids retention time on estrogen 
degraders and their associated microbial community in lab- and full-scale bioreactors.  
Finally, Section 7 summarizes significant findings of this research and recommendations 
for future study. 
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2. LITERATURE REVIEW 
 
2.1 Sources and Properties of Estrogens and Their Roles in Endocrine System 
Estrogens are considered as endocrine disrupting compounds (EDCs) that have 
shown adverse health impacts on aquatic wildlife (1-10).  Synthetic estrogens, such as 
DES (diethylstilbestrol), are known to disrupt the human reproductive system (11, 28). 
Estrogens are reproductive hormones and can be produced naturally and synthetically 
(18).  Natural estrogens include estrone (E1), 17β-estradiol (E2), estriol (E3), and 17α-
estradiol (an isomer of E2), and synthetic estrogen includes 17α-ethinyl estradiol (EE2) 
commonly used for oral contraceptives. 
Estradiol is produced mainly from the ovaries, the corpus luteum, and the 
placenta to develop follicles in premenopausal women.  In postmenopausal women and 
men, estradiol is produced from many extragonadal sites including breast, osteoblasts 
and chondrocytes of bone, vascular endothelium and aortic smooth muscle cells, and 
brains (29).  More than 50% of the estrone is produced the peripheral tissue conversion 
of androstenedione in ovaries (30).  Estriol is derived from estrone, estradiol, and 
androstenedione in the body (30). 
Structurally, natural estrogens contains 18-carbon steroids with a phenolic-A ring, 
which has a high-affinity binding to the estrogen receptors, while the structure of 17α-
ethinyl estradiol is similar to natural estrogen with the ethinyl substitution at carbon 17 
(Figure 2.1). 
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          Estrone          17β-estradiol                 Estriol                  17α-ethinyl estradiol  
(E1, natural) (E2, natural)             (E3, natural)                  (EE2, synthetic) 
  
Figure 2.1.  Chemical structures of estrogens (18, 31). 
  
The solubility of estrogens in water ranges from 1.3 to 13 mg/L (Table 2.1); 
however, the solubilities in nitrate mineral salts medium are 2.6-3.0 mg/L for 17β-
estradiol and 1.0-1.3 mg/L for estrone in our laboratory.  The vapor pressure of estrogens 
is low (6 x 10-15~2 x 10-10 mm Hg) and the melting temperature is high for all estrogens 
(Table 2.1) (32-35).  Estrogens have been used as oral contraceptives, in hormone 
replacement therapy for human, and veterinary medicine (16).  Estrogenic products are 
also used to enhance the growth of livestocks (18).  After being metabolized in the 
human body, estrogens are excreted with their metabolites such as estriol, 2-methoxy-
estrone, 2-hydroxy-ethinyl  estradiol, and 2-methoxy-ethinyl estradiol in urine and feces 
(16, 36).   A normal female usually releases 5-100 µg/d, and a pregnant woman can 
excrete estrogens up to 30 mg/d.  Even men release 2-25 µg/d of estrogens (16).  
Similarly, estrogens are released from livestock (37).  The excreted estrogens from 
humans may be introduced into wastewater treatment plants.  After wastewater treatment 
processes, the effluent of wastewater treatment plants containing untreated estrogens and 
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the sludge treatment for agricultural use are an important contaminant source of 
estrogens in environment (5, 18, 19, 38).  
 
Table 2.1  Properties of estrogens 
Name 17α-estradiol 
Estrone 
(E1) 
17β-
Estradiol 
(E2) 
Estriol 
(E3) 
17α-ethinyl 
estradiol 
(EE2) 
Chemical 
formula 
C18H24O2
(natural) 
C18H22O2
(natural) 
C18H24O2
(natural) 
C18H24O3
(natural) 
C20H24O2
(synthetic) 
Molecular 
weight 272.4 270.4 272.4 288.4 296.4 
Melting 
Point (°C)1,2 223-226 255-262 178-179 280-282 - 
Water 
Solubility 
(mg/L) 1,2,
1.33-3.9 12.4-13 13 13 4.8 
LogKow1,2 3.54-4.0 3.43 3.94 2.81 4.15 
Vapor 
pressure 
(mmHg) 1
- 2.3x10-10 2.3x10-10 6.7x10-15 4.5x10-11
1  Ingerslev and Halling-Sorenson, 2003 (32) 
2  Beck et al., 2008 (33) 
3  Rytting et al., 2005 (35) 
4  Xia et al., 2005 (34) 
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2.2 Current Technologies for Estrogen Removal 
2.2.1 Physical Process 
Powdered activated carbon (PAC) has been reported to remove estrogens 
successfully (> 95%) from raw drinking water (39).  PAC removed  endocrine disrupting 
compounds in the order: 17β-estradiol > 17α-ethinyl estradiol > bisphenol A (40).  
Longer contact time and higher dose of PAC are required for better removal efficiencies 
of estrogens, and natural organic matters (NOMs) may inhibit the estrogen removal by 
PAC (39, 40).  Granular activated carbon (GAC) adsorbs 17β-estradiol from deionized 
water quickly (41).  However, the coagulation-filtration process is not effective for 
estrogen removal (42). 
2.2.2 Chemical Process  
Estrogens have low solubility in water.  However, estrogens are lipophilic and 
can be removed by chemical processes such as ozonation, UV radiation, advanced 
oxidation, and chlorination.  Chemical oxidation has been shown as an effective process 
for removing estrogen compounds. Huber et al. (2003) reported that conventional 
ozonation and advanced oxidation processes could oxidize 17α-ethinyl estradiol in a 
drinking water treatment plant (43).  Titanium dioxide (TiO2) suspension under UV 
radiation can degrade natural and synthetic estrogens (44).  Rosenfeldt and Linden 
(2004) applied ultraviolet (UV) radiation photolysis and the UV/hydrogen peroxide 
(H2O2) advanced oxidation process (AOP) to degrade endocrine disrupting compounds 
including 17α-ethinyl estradiol and 17β-estradiol. Both processes removed all the tested 
EDCs effectively and the UV/H2O2 AOP was better than UV photolysis (45).  Synthetic 
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manganese oxides (MnO2), a chemical oxidizing agent, were able to oxidize natural and 
synthetic estrogens in water effectively at pH 4.0 (46).  Chlorination is a common 
disinfection process for water and treated wastewater.  During the chlorination process,  
17β-estradiol was rapidly degraded, and chlorinated derivatives of estrone were 
produced.  Low or no estrogenic activities were found in the chlorinated derivatives (47-
49).  
2.2.3 Biological Process 
Numerous studies have investigated the fate of estrogens in wastewater treatment 
plants (WWTPs) and observed the degradation of natural and synthetic estrogens by 
biological process.  (9, 17, 21, 50-56).  The removals of estrogens by WWTPs varied 
from 19 to 98% for estrone, from 76 to 98% for 17β-estradiol, and 83-90% for 17α-
ethinyl estradiol, depending on the operation status, location of plants, and influent 
estrogen concentrations (9, 17, 21, 50-56).  Several studies isolated estrogen-degrading 
microorganisms from activated sludge (23-26, 57, 58).  Novosphingobium tardaugens 
ARI-1 was isolated from activated sludge as a 17β-estradiol degrader (24).  Nitrifying 
activated sludge and ammonia-oxidizing bacterium Nitrosomonas europaea degraded 
natural (estrone, 17β-estradiol, estriol) and synthetic estrogens (17α-ethinyl estradiol) 
significantly.  The first-order degradation rate constants are 0.056 h−1 for estrone, 1.3 h−1 
for 17β-estradiol, 0.03 h−1 for estriol, and 0.035 h−1 for 17α-ethinyl estradiol (23).  Shi et 
al. also isolated ethinyl estradiol degrading bacterium Fusarium proliferratum strain 
HNS-1 from a cowshed sample (57).  Two Rhodococcus strains were isolated from 
activated sludge as estrogen degraders (25).  Rhodococcus zopfii and Rhodococcus equi 
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degraded natural and synthetic estrogens rapidly and completely, and no estrogenic 
activities were observed after degradation.  Weber et al. found that Achromobacter 
xylosoxidans and Ralstonia picketii transformed 17β-estradiol and estrone into estriol 
and 16α-hydroxyestrone (26).  Three estrogen degraders were also isolated from a sandy 
aquifer (58).  Acinetobacter strains (LHJ1 and LHJ3) and a Sphingomonas strain CYH 
degraded 17β-estradiol and estrone both in aerobic and anoxic conditions.   Li et al. (59) 
showed the estrogen degradation by activated sludge with a first-order degradation rate 
constants of rate 0.2-4.8 h-1.  Fourteen phylogenetically diverse 17β-estradiol-degrading 
cultures (strains KC1 through KC14) were isolated from activated sludge in our 
laboratory (27).  These strains showed three different degradation patterns of estrogens.   
Details of the degradation patterns toward estrogens were available on pages 42-45.   
A microbial degradation pathway for 17β-estradiol has not been identified.   On 
the other hand, a 17α-ethinyl estradiol degradation pathway by Sphingobacterium sp. 
JCR5 (Figure 2.2) and a testosterone degradation pathway by C. testosteroni TA441 
(Figure 2.3) have been proposed by Haiyan et al.(60) and Horinouchi et al. (61).  
As shown in Figure 2.2, the A-ring of 17α-ethinyl estradiol was cleaved by a 
dioxygenase (R4 in Figure 2.2), while the A ring of testosterone was cleaved by meta-
cleavage enzyme (reaction 5 in Figure 2.3).  Since 17β-estradiol is structurally similar to 
17α-ethinyl estradiol and testosterone, the degradation pathway of 17β-estradiol might 
be similar to those two proposed pathways.  Hence, these two proposed pathways for 
17α-ethinyl estradiol and testosterone can be used as a starting point for elucidating the 
degradation pathway of 17β-estradiol.  
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In this study, the activity of nonspecific oxygenase enzymes in three estrogen-
degraders (strains KC6, KC7, and KC8) was examined using nonspecific 
monooxygenase and dioxygenase enzyme assays.  The activity of nonspecific 
monooxygenase enzyme was detected using a naphthalene oxidation assay (62).  The 
activity of a nonspecific dioxygenase was detected using an indol oxidation assay (63).  
 
 
 
 
Figure 2.2   Proposed pathway of 17α-ethinyl estradiol degradation in Sphingobacterium. 
JCR5 (60). Dioxygenase enzyme might catalyze the reaction R4 for cleavage between 
C4 and C5. 
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Figure 2.3  Proposed pathway of testosterone degradation by Comamonas testosteroni 
(61). Meta-cleavage enzyme gene, tesB might catalyze the conversion of 3,4-DHSA to 
4,9-DHSA in reaction 5. 
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2.3 Growth and Degradation Kinetics 
2.3.1 Yield and Doubling Time 
Cellular yield (Y) was estimated by dividing the amount of cell biomass 
produced over the amount of substrate utilized.  The Y is expressed as: 
 
  1 2
1 2
(
( )
)X X XY
S S S
∆ −= − = −∆ −                                                                                    (2-1) 
in which 
 Y= cellular yield (biomass produced/mass of substrate utilized); 
 ∆X= amount of biomass produced (mass/volume); 
 X1 = initial biomass concentration (mass/volume); 
 X2 = final biomass concentration (mass/volume); 
 ∆S= amount of substrate concentration utilized (mass/volume); 
 S1 = initial substrate concentration (mass/volume); 
 S2 = final substrate concentration (mass/volume). 
 
Cellular yields of aerobic heterotrophs were reported to be 0.49 gVSS(volatile 
suspended solids)/gBODL with carbohydrate BOD and 0.42 gVSS/gBODL with other 
electron donors (64).   
Doubling time (τd) is defined as the time needed for a microbial population to 
double in number.  From a growth curve, τd can be estimated from the exponential 
growth phase using the following equation: 
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2 0.693
d
Lnτ µ µ= =                                                                                              (2-2) 
in which 
 τd = doubling time (time); 
 µ = specific growth rate (time-1). 
 
2.3.2 Monod Kinetics 
The widely applied relationship to address bacterial growth kinetics is the Monod 
equation which shows the relationship between the specific growth rate (µ) of a 
microbial population and the substrate concentration (64):  
 
  1( )asyn syn m
a m
dX S
X dt K S
µ µ= = +                                                                       (2-3) 
in which 
 µsny = specific growth rate due to cell syntheses (time-1); 
 Xa    = active biomass concentration (mass/volume); 
t    = time; 
 S    = substrate concentration (mass/volume); 
 µm  = maximum specific growth rate (time-1); 
Km  = half velocity constant or saturation constant (mass/volume). Substrate 
   concentration corresponding to one-half of maximum specific growth rate. 
 
Then µ and µm in equation (2-3) can be replaced with equation (2-4) into equation (2-5) 
for the nonlinear regression analysis. 
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  q Yµ = ⋅    and  m mq Yµ = ⋅                                                                             (2-4) 
in which 
 q  = substrate utilization rate (time-1). 
 qm= maximum substrate utilization rate (time-1) 
 
  m
m
q Sq
K S
= +                                                                                                        (2-5) 
 
The kinetic parameter, maximum specific growth rate (µm), describes the rate of 
cell growth and half velocity constant (K ) indicates the affinity to substrates.  For 
aerobic heterotrophs in activated sludge, typical maximum substrate utilization rate (qm) 
and maximum specific growth rate (µm) are 20-27 gBODL/gVSS-d  and  8.4-13.2 
gVSS/gBODL-d , respectively (64).  Nonlinear regression using Sigmaplot 2002 (SPSS 
Inc.) was conducted to estimate the kinetic parameters, the maximum substrate 
utilization rate (qm) and half velocity constant (K ). Then the maximum specific growth 
rate (µm) was calculated by equation (2-4).   
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2.4 Molecular Tools Used in This Study 
2.4.1 Real-Time PCR 
While the traditional PCR amplifies specific DNA sequences from a DNA 
mixture of DNAs, the real-time PCR, a fluorescence-based kinetic PCR assay, allows 
rapid quantification of the initial number of copies of the target gene (65, 66).  The real-
time PCR assay amplifies a target gene with a fluorescence-labeled primer and a probe 
and quantifies a fluorescent signal which increases proportionally with the amount of 
PCR product.  The amount of fluorescence emitted at each cycle is recorded and the 
PCR reaction for the first significant increase of PCR product correlating to the initial 
amount of target template is monitored.  The significant increase of the fluorescence 
occurs when the starting copy number of the target gene is higher.  The significant 
increase of fluorescence signal is compared to the standard curve and quantifies the 
target gene (67).  Real-time PCR has been used to quantify various targets such as 
pathogens(68, 69), viruses(70, 71), and specific species (72-77)).   
2.4.2 Real-Time-t-RFLP 
Real-time terminal restriction fragment polymorphism (real-time-t-RFLP) is a 
quantitative fingerprinting method capable of determining the diversity and the 
abundance in a microbial community structure simultaneously (78). Real-time-t-RFLP 
assay was developed by combining two molecular technologies, real-time PCR (65, 66, 
79) and t-RFLP (80-82).  During the first step, the 16S rRNA genes of genomic DNA 
sample are amplified and quantified by a fluorescence-labeled primer and a 
fluorescence-labeled probe.  While the fluorescent-labeled primer is incorporated into 
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the PCR products, the fluorescent-labeled probe emits a signal for rapid quantification 
after being cleaved from a complementary region of the target gene.  Then the harvested 
labeled-PCR products are digested with a restriction enzyme, followed by analysis with 
an automatic sequencer to produce a series of T-RF profiles. Finally the relative 
abundance of each species in a microbial community is determined (Figure 2.4) (78). 
 
 
 
Figure 2.4  Real-time-t-RFLP assay for quantitative fingerprinting of microbial 
communities (78). 
 
 
 18
2.5 Estrogenic Screen Assays 
 Due to concern for the adverse effects of EDCs on wildlife and human health, it 
is necessary to screen and detect the present of EDCs and their estrogenic activities in 
environments.  The estrogenic potential can be determined via two different types of 
estrogenic screen assays, in vivo and in vitro assays.  The in vivo estrogenic assay 
measures the in vivo responses to estrogen exposure. Mouse uterotrophic assay and 
vitellogenin (VTG) assay are two commonly used in vivo assays.  The in vitro estrogenic 
assays are used to evaluate estrogenic potencies by using transgenic human breast cancer 
cell lines (MVLN or MCF cells), or a recombinant yeast cell.  Compared to the  in vitro 
assays, the in vivo assay are more costly and time consuming.  Relative estrogenic 
potencies measured by in vivo and in vitro assays are shown in Table 2.2. 
2.5.1 In Vivo Estrogenic Screen Assay 
Numerous studies investigated estrogenic activities by using in vivo assays.  The 
classic and sensitive in vivo estrogenic assay is the mouse uterotrophic assay. The mouse 
uterotrophic assay is able to detect estrogenic activity for multiple estrogen compounds 
(83).  Another commonly used in vivo estrogenic assay is the vitellogenin (VTG) assay.  
Vitellogenin is a specific protein and yolk protein precursor in females of fish, 
amphibians, reptiles (including birds), insects and the platypus.  Exposure to estrogenic 
compounds can induce vitellogenin and vitellogenin can be detected at very low levels in 
males.  Therefore, the vitellogenin become an effective biomarker for estrogenic activity 
(5, 10, 84, 85).  However, it is still not clear how the vitellogenin levels are closely 
related to the adverse impacts on gonads and reproductive success or development of 
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progeny (86).  Folmar et al. investigated the estrogenic activity of the effluent of 
wastewater treatment plants (5).  The plasma vitellogenin level was elevated in male 
carp in the downstream of the effluent of sewage treatment plants; on the contrary, 
testosterone level in male carp decreased (5, 18).  Segner et al. (87) and Hemmer et al. 
(88) investigated the induction of vitellogenin in zebra fish and sheepshead minnow with 
the in vivo VTG estrogenic screen assay.   
2.5.2 In Vitro Estrogenic Screen Assay 
In vitro assays are relatively more rapid and cost effective than in vivo assays. 
The yeast estrogen screen (YES) with a recombinant yeast strain (Saccharomyces 
cerevisiae) was developed by expressing human estrogen receptor (hER) and two 
estrogen response elements (ERE) linked to the lacZ gene (84, 87, 89, 90).  Since the 
MCF-7 human breast cancer cells proliferate in the presence of chemicals that directly or 
indirectly activate the estrogen receptor, the E-screen assay was developed by comparing 
the cell number achieved by similar inocula of MCF-7 cells in the absence and presence 
of 17ß-estradiol and a range of concentrations of concern (84, 91-93).  The MVLN-assay 
was developed by using the MVLN-cell, the human breast cancer cell (94).  These 
assays were applied to detect estrogenic activity in sewage effluent, surface, and other 
water environments (19, 92, 95). Relative estrogenic potencies are shown in Table 2.2. 
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Table 2.2  Relative estrogenic potencies 
In vitro assay In vivo assay 
Name 
YESa MVLNb E-screenc VTGd
17β-Estradiol 
Estrone 
Estriol 
17α-ethinyl estradiol 
1 
0.4 (1)
- 
0.7 (4)-0.96 (3)
1 
0.01 (2)-0.2 (1)
0.083 (2)
1.25 (2)-1.6 (1)
1 
0.01 (4)
- 
1.25 (2)-1.9 (4)
1 
0.5 (5)-0.8 (1)
0.001 (6)
30.6 (1)
 
(1)  Van den Belt et al. (86)   (2)  Gutendorf and Westendorf (92) 
(3)  Segner et al. (87)    (4)  Folmar et al. (84) 
(5)  Routledge et al. (38)   (6)  Metcalfe et al. (96) 
a   YES: Yeast estrogen screen assay 
b   MVLN: Assay using MVLN, the human breast cancer cell lines 
c   E-screen: Assay using MCF-7, the human breast cancer cell lines 
d   VTG: Vitellogenin assay  
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3. MATERIALS AND METHODS 
 
3.1 Materials 
3.1.1 Chemicals 
Three estrogens (17β-estradiol (> 99% pure), 17α-estradiol (> 98% pure), and 
estrone (> 98% pure)) were purchased from Sigma-Aldrich Inc. (St. Louis, MO).  
Testosterone was purchased from Pfaltz and Bauer, Inc. (Waterbury, CT).  Due to low 
solubility of estrogens and testosterone, stock solutions were prepared in acetone and 
stored at 4 °C. Bicinchoninic acid (BCA) protein assay reagent kit, pyridine, 
dimethylformamide (DMF) and N,O-bis(trimethylsilyl) trifluoroacetamide (BSTFA) 
were purchased from Pierce Biotechnology Inc. (Rockford, IL).  Sodium formate (ACS 
reagent grade) and glycerol (ultra pure) were purchased from MP Biomedicals, Inc. 
(Solon, OH).  Tetrazotized o-dianisidine was purchased from Fluka Chemical Corp. 
(Ronkonkoma, NY).  Naphthalene (99.6%) was obtained from Alfa Aesar (Ward Hill, 
MA).  NADH was produced from Research Organics (Cleveland, OH).   Dithiothreitol 
(DTT) was produced from Promega Corp. (Milwaukee. WI).  Ferrous sulfate, triclosan 
(97%) and indol (>99%), phenol were purchased from Mallinckrodt Baker, Inc. 
(Philipsburg, NJ) and Sigma-Aldrich Inc. (St. Louis, MO), respectively.  Naphthalene 
(99.6%) and sodium succinate were purchased from Alfar Aesar (Ward Hill, MA). 
Bisphenol A (2,2-bis(4-hydroxyphenyl)propane) and naphthol were obtained from TCI 
America (Portland, OR). Glucose was obtained from EM Science (Gibbstown, NJ).  
GeneScan 500 Rox size standard was purchased from Applied Biosystems (Warrington, 
United Kingdom). QuantiTect probe PCR supermix and SYBR Green I (as a double 
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stranded DNA binding fluorescent dye) were purchased from Qiagen (Valencia, CA).  
For synthetic wastewater, sodium acetate, ammonium chloride, ammonium sulfate, 
sodium bicarbonate, magnesium sulfate, potassium biphthalate, sodium hydroxide, 
sodium nitrite, sodium nitrate, zinc sulfate, and cobalt chloride were purchased from 
EMD Chemicals Inc. (Gibbstown, NJ).   Calcium chloride, ferrous sulfate, manganese 
chloride, potassium phosphate, sodium carbonate, sodium phosphate, and EDTA were 
obtained from Mallinckrodt Baker, Inc. (Phillipsburg, NJ).  Copper sulfate and 
ammonium molybdate were obtained from VWR International (West Chester, PA). 
3.1.2 Bacterial Strains and Growth Conditions 
Three estrogen-degrading bacterial strains, KC6, KC7, and KC8 (all gram 
negatives, Genbank accession numbers DQ066436-DQ0664368, respectively) were 
isolated from activated sludge of a wastewater treatment plant in Knoxville, Tennessee  
(27).  Novosphingobium tardaugens ARI-1 (gram negative, Genbank accession number 
AB070237) was purchased from the American Type Culture Collection (ATCC #BAA-
531).  Nitrosomonas europaea was a gift from Dr. Michael Hyman at the Department of 
Microbiology in North Carolina State University.  Strains KC6, KC7, and KC8, and 
ARI-1 were grown in tryptic soy broth (TSB) containing 3mg/L of 17β-estradiol at 
30 °C at 150rpm for 2 d before harvesting for experimental use.  The growth medium for 
Nitrosomonas europaea contains 3.3g (NH4)2SO4, 0.41g KH2PO4, 0.75mL of 1M 
MgSO4, 0.2mL of 1M CaCl2, 0.33mL of 30mM FeSO4/50mM EDTA, 0.01mL of  
50mM CuSO4, 5.444g KH2PO4, 0.48g NaH2PO4, 0.04% Na2CO3 in 1.0 L.  NaOH(10N) 
was used to adjust a pH 8.0 (97).  The cells were grown in dark room at 30 °C at 150rpm 
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for 3-5 d before harvesting for experimental use.  The nitrate mineral salts (NMS) used 
in this study contains 11.76 mM NaNO3, 0.98 mM K2SO4, 0.15 mM MgSO4⋅7H2O, 0.07 
mM CaSO4⋅2H2O, 0.08 mM FeSO4⋅7H2O, 3.9 mM KH2PO4, 6.1 mM Na2HPO4, 0.1 mM 
H2SO4, 0.001 mM KI, 0.002 mM ZnSO4⋅7H2O, 0.002 mM MnSO4⋅H2O, 0.002 mM 
H3BO3, 0.004 mM CoMoO4⋅H2O (98). The acetone-free nitrate mineral salts (NMS) 
medium containing estrogens or other targets (testosterone, bisphenol A, or triclosan) 
was prepared as follows: Following the additions of the known amounts of target stock 
solutions in acetone, acetone was evaporated by purging with nitrogen gas for 5-10 
minutes. Then NMS medium was added in the reactor, and the targets were resuspended 
at 150rpm at room temperature for 2-3 d. 
3.1.3 Sequencing Batch Reactors 
Three laboratory-scale sequencing batch reactors (SBR) were constructed with 
Erlenmeyer flasks (2.0 L).   Water-vapor-saturated air was continuously bubbled into the 
bioreactors to maintain dissolved oxygen concentrations in the range between 4 and 6 
mg/L.  The water-vapor-saturated air was generated by passing ambient air though a 
flask containing DI water.  The SBR reactors were inoculated with activated sludge in 
synthetic wastewater (1.5 L), resulting in an initial MLVSS concentration of 1,320 mg/L.   
The activated sludge was collected from a local municipal WWTP in College Station, 
TX.  The synthetic wastewater contained acetate (measured as total organic carbon 
(TOC) =175 mg/L), ammonia (as total nitrogen =25 mg/L) and inorganic nutrients.  The 
synthetic wastewater contained 512 mg NaCH3COO, 166 mg NaHCO3, 107 mg NH4Cl, 
75.5 mg NaH2PO4·2H2O, 90 mg MgSO4·7H2O, 36 mg KCl, 14 mg CaCl2·2H2O, 18 mg 
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EDTA, 1 mg yeast extract, 1.5 mg FeSO4·7H2O, 0.0015 mg H3BO3, 0.48 mg 
CuSO4·5H2O, 0.003 mg KI, 1.5 mg MnCl2·4H2O, 0.33 mg (NH4)6Mo7O24·4H2O, 0.66 
mg ZnSO4·7H2O, and 0.015 mg CoCl2·6H2O in 1.0L (99).  A cell suspension containing 
strain KC8 was spiked into the SBR to result in an initial concentration of 2.2x108 
16rRNA gene copies of strain KC8/mL.  All reactors were operated at a hydraulic 
retention time of 36 h and a cycle of 24 h.   The 24-h cycle consisted of a 22-h fill-mix-
reaction phase and a 2-h settle-and-draw phase.   In the beginning of each cycle (i.e., 
every 24 h), 17β-estradiol was added into the SBRs to bring the initial concentration of 
1mg/L.  The three SBRs (referred as SBR-5d, SBR-10d, and SBR-20d hereafter) were 
operated under three different SRTs of 5, 10, and 20 d.  Each solids retention time of 5, 
10, and 20 d was controlled by removing 300, 150, and 75 mL of MLSS including the 
sample volume from the reactor at each cycle.  Also, hydraulic retention time (36 h) was 
controlled by removing 700, 850, and 925 mL of supernatant after settle phase from the 
reactor operating under 5, 10, 20 d of SRT, respectively.  Liquid samples were collected 
from the bioreactors after mixing phase and after settling phase of each cycle.   Collected 
samples were analyzed for estrogen, MLVSS, TOC, total nitrogen (TN), and estrogen-
degrading cultures.  Synthetic wastewater (1.0 L) was added to keep the reactor volume 
(1.5 L) at the fill phase into each reactor with 17β-estradiol.  
3.1.4 Sampling from Wastewater Treatment Plants 
Three WWTPs in College Station, Austin, and Houston, TX, were chosen for this 
study because of their different configurations in biological treatment processes and 
operating conditions.   These WWTPs are designed for BOD removal and nitrification to 
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treat 10 to 200 million gallons of wastewater daily.   The SRTs of the three WWTPs 
ranged from 7 to 30 d.  Other information of each WWTP is summarized in Table 3.1.  
Activated sludge samples were collected from the aeration tanks (MLVSS = 1.1~2.2 
g/L) of the WWTPs.  The genomic DNA of the activated sludge samples were extracted 
and used for molecular quantification of 16S rRNA genes of strains ARI-1, KC8, AOB, 
and amoA genes. 
 
Table 3.1.  Operation parameters of WWTPs for activated sludge sampling 
WWTP #3 
WWTPs WWTP #1 WWTP #2 
1st stage 2nd stage 
Capacity (MGD) 9.5 75 200 
SRT (d) 7-8 10-12 2 20-30 
MLVSS (g/L) 2.15 1.52 1.35 1.10 
BOD5 removal 
 (%) 97-98 97-99 91-99 
Operating 
parameters 
Ammonia 
removal (%) 95 99 84-99 
 
 
 26
3.2 Experimental Methods 
3.2.1 Estrogen Degradation Tests 
Experiments were designed to examine whether strains KC6, KC7, and KC8 
were capable of degrading 17β-estradiol and estrone. 17β-Estradiol and estrone were 
used as two model compounds.  The degradation tests were conducted in a series of 300-
mL vials containing 100 mL of resting estrogen-degrading cells, and an initial 
concentration of 3 mg/L of 17β-estradiol or estrone.  Strains KC6, KC7, and KC8 were 
pre-grown overnight in tryptic soy broth (TSB) medium containing 3 mg/L of 17β-
estradiol before harvesting by centrifugation for experimental use.  The harvested cells 
were washed with 10 mM phosphate buffered saline (pH 7.0, containing 10 mM NaCl 
and 2.5 mM KCl) before re-suspending in the acetone-free, NMS-estrogen growth 
medium to an optical density (OD600) of 0.5.  The vials were incubated on a rotary 
shaker at 150 rpm at 30ºC.  Liquid samples collected over time were analyzed for 17β-
estradiol and estrone concentrations by GC/MS analysis.  All degradation tests were 
performed in duplicate.  Autoclave-killed controls were used. 
3.2.2 Cell Growth Tests 
Strains KC6, KC7, and KC8 capable of degrading both17β-estradiol and estrone 
were further examined for their abilities to use 17β-estradiol as a sole carbon source.   
Sufficient 17β-estradiol in acetone-free NMS growth medium during the tests was 
prepared as described below.  A known amount of stock solution (containing 20 mg of 
17β-estradiol) was first added into a 300-mL flask followed by gentle purging with 
nitrogen to evaporate the acetone in the flask.  After complete evaporation of acetone, 
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100 ml NMS medium was added into the flask to dissolve estrogen.  The flask was 
shaken at 150 rpm for 2 d before inoculated with isolates.  The flasks were incubated at 
30 °C at 150 rpm for 25 d.  Negative controls containing only NMS medium and cells 
(no 17β-estradiol) were used. Samples were collected over time for 17β-estradiol 
analysis and protein content measurements.  The protein content was determined using a 
BCA protein assay kit. 
3.2.3 Ability to Utilize and/or Degrade Macro- and Micro-pollutants in Wastewater 
Experiments were conducted to examine whether strain KC8 can utilize and/or 
degrade common organic constituents (both macro- and micro-pollutants) in wastewater.  
Four different organics (phenol, glucose, sodium succinate, and sodium acetate) and 
three micropollutants (testosterone, bisphenol A and triclosan) were used.   The substrate 
utilization tests were conducted similarly in flasks as described by Yu et al. (27).  The 
flasks (300 mL) were inoculated with strain KC8 (an initial optical density OD600 of 
0.02) and one of the organic substrates: 20 mg phenol (to avoid toxicity (100)), 300 mg 
glucose, 300 mg sodium succinate, 175 mg sodium acetate in 100 mL, or 20 mg 
testosterone in nitrate minimum salts (NMS) medium (150 mL).  The flasks were 
incubated at room temperature at 180 rpm on a shaker.  Negative controls containing 
autoclave-killed cells in NMS medium were used.  Cell growth was monitored over time.   
The biomass concentrations were expressed as turbidity at A600 (OD600) or as protein 
content.  The absorbance of liquid samples at A600 was measured using a Hewlett 
Packard G1130A UV-visible spectrophotometer.  The protein content was determined 
using a BCA protein assay kit.   
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The substrate degradation tests for micro-pollutants (triclosan, bisphenol A, and 
testosterone) were conducted in 300 or 500 mL Erlenmeyer flasks containing NMS 
medium with resting cells of strain KC8 (with an optical density (OD600) of 0.5), 0.5 
mg/L of triclosan or bisphenol A, 1.5 mg/L of testosterone.  The resting cell suspension 
was prepared as described in degradation kinetic tests. Acetone-free NMS medium was 
used. The flasks were incubated at room temperature at 180 rpm on the shaker for 7 d.  
Liquid samples were collected over time for triclosan, bisphenol A, and testosterone 
analysis. Autoclave-killed cells were used for controls. Concentrations of triclosan, 
bisphenol A, and testosterone were determined by GC/MS analyses. 
3.2.4 Estrogen-Testosterone Utilization Kinetics 
Substrate utilization kinetic tests were conducted in a series of EPA vials (40 
mL) containing 10 mL of resting-cell suspension with OD600 of 0.5 and estrogens or 
testosterone.  Initial concentrations ranged from 0.05 to 10 mg/L for 17β-estradiol, from 
0.05 to 6 mg/L for estrone, and from 0.05 to 10 mg/L for testosterone.   After adding cell 
suspension, the vial was vigorously shaken by hands for 30 sec before the first sample 
was taken.  After 2 h of incubation at room temperature at 180 rpm on the shaker, the 
vials were sacrificed for estrogen and protein analyses.  The incubation duration (2 h) 
was determined in the laboratory where initial degradation rates remained linear. 
3.2.5 Effects of Complex Nutrients on Estrogen Degradation 
Experiments were conducted to determine whether strain KC8 could retain its 
degradation ability toward estrogens after growing on a complex nutrient medium 
without exposure to 17β-estradiol for a period of time.  The complex-nutrient-grown 
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cells were prepared as follows.  Strain KC8 was grown and sub-cultured on 17β-
estradiol-free-R2A agar plates every 3 d.  After five transfers (i.e., 15 d), the cells were 
then grown in tryptic soy broth (TSB) overnight before harvested for 17β-estradiol 
degradation tests.  
3.2.6 Development of Real-time-PCR Assay for Estrogen Degraders 
Real-time TagMan PCR assays were developed for quantification of two known 
estrogen degraders, strains KC8 (256 bp long) and ARI-1 (206 bp long).   The primer 
sets and TaqMan probes were designed to target the 16S rRNA gene sequences of KC8 
and ARI-1.  For strain KC8, the primers (KC8f (5’-ACCAGAGATGGTTTCCTTCAGT 
-3’) and KC8r(5’-GCTTGCTG- CCCACTGTAGTT-3’)) and probe (KC8 Taq (5’-
[DFAM]ATAGGTGACAGGTGCTGCATGGCTGT[DHH1]-3’)) were designed based 
on the alignments of 8 closely related bacterial 16S rRNA gene sequences (>92% 
similar) (AY771798, AY771797, AY771794, X94101, AJ009706, AJ292601, 
DQ177493 and AY509242) with KC8 16S rRNA gene sequence (DQ066438).   
Similarly, primers (ARI-1f (5’-GCTGTCCGGGCTCATGGAGT-3’) and ARI-1r (5’-
CCCGAAGGGAACACCCAATCT-3’)) and TaqMan probe (ARI-1 Taq(5’-[6-
FAM]ACCAGC- GTTTGACATCCCGCGCTAA[TAMRA-6-FAM]-3’)) were designed 
to target the 16S rRNA gene sequence (AB070237) of ARI-1 strain.  Twenty-eight 
closely related bacterial 16S rRNA gene sequences (EU127294, DQ985055, AB219359, 
AY690709, AB177883, AJ416411, AJ303009, AB025012-4, U20756, U20773-4, 
AJ001051, DQ840049, EF628247, EF421434, EF044233, AB023290, AJ009707, 
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AJ000920, AJ746092, AJ746094, AB110635, AF411072, AB362778, AB220123, 
AB220125) were used for the design.    
The specificity of designed primers and probes were checked using the Basic 
Local Alignment Search Tool (BLAST) of GenBank.  Based on the available sequences 
in GenBank (accessed on 9/29/2005), primers (KC8f and KC8r) and probe (KC8 Taq) 
had at least three total mismatches after comparing with more than 100 bacterial 16S 
rRNA gene sequences from BLAST as well as 8 closely related bacterial 16S rRNA 
gene sequences as mentioned above. Therefore, the designed primers and probe can 
discriminate 16S rRNA gene sequences of strain KC8 from closely related strains.   
Similarly, the primers (ARI-1f and ARI-1r) and probe (ARI-1 Tag) had also at least 3 of 
total mismatches after comparing with bacterial 16S rRNA gene sequences, based on the 
available sequences deposited in GenBank (accessed on 3/13/2008). 
 
3.3 Analytical Methods 
3.3.1 Estrogens and Testosterone Analysis 
Estrogen concentrations in liquid samples (containing cells and growth medium) 
were determined by GC/MS analysis as described by Yu et al. (78).  Briefly, the 
estrogens in liquid samples were extracted with ethyl ether, resuspended with DMF, and 
then derivatized with BSTFA.  The derivatized samples were injected into an Agilent 
6890 Network Gas Chromatograph equipped with a DB-5MS capillary column (J&W 
Scientific; 30 m x 0.25 mm i.d.; 0.25 µm film thickness) and an Agilent 5973 Network 
Mass Selective Detector. The analysis was performed in the SIM (selective ion 
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monitoring) mode.  The primary ions selected for quantification were m/z 416 for 17β–
estradiol and m/z 342 for estrone.  The GC column temperature was initially set at 
240 °C for 2 min, then ramped at 10 °C /min to 300 °C, and held constant for 3 min.  
Helium was the carrier gas and a flow rate of 1 mL/min was used.  The detection limits 
for 17β-estradiol and estrone were 5 µg/L.  
Similarly, testosterone concentrations in samples were measured by GC-MS 
analysis.  Liquid samples containing testosterone were extracted with the same volume 
of ethyl ether. Then testosterone was resuspended with pyridine (250µL), and then 
derivatized with BSTFA (250µL) with 1% TMCS (trimethylchlorosilane).  The 
derivatized samples were injected into the same GC/MS system using SIM mode.  The 
column and the configurations of column temperature were same as used for estrogen 
measurement.  The primary ion, m/z 432, was selected for testosterone quantification.  
The detection limit for testosterone was 50 µg/L.  Concentrations of bisphenol A and 
triclosan were determined as described by Zhao (101) and Subramanya (102).  The 
extraction and derivatization methods, and GC-MS equipments used for bisphenol A or 
triclosan were same as used for estrogen measurement.  The injector temperature was 
250 °C.  The initial oven temperature was set at 80 °C, then increased to 280 °C with a 
rate of 30 °C/min and held for 3 min, then increased to 300 °C and held for 3 min.  The 
SIM mode was used with the selected ions of 357 m/z and 372 m/z for bisphenol A and 
200 m/z and 360 m/z for triclosan.  The detection limits for triclosan and bisphenol A 
were 50 and 10 µg/L, respectively. 
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3.3.2 Protein Assay, Mixed Liquor Volatile Suspended Solids, and Optical Density 
The cellular proteins in the samples were released by using a sonicator (Branson 
Sonifier-150) at a power of 50 watts for 10 sec (103).  The treatment was repeated for 
three times before cooling the samples on ice for 45 sec.  The released protein content 
was then determined using a BCA protein assay kit by following the manufacturer’s 
instructions with a detection limit of 5 µg/mL.  Mixed liquor volatile suspended solids 
(MLVSS) concentrations in liquid samples were determined by dividing the difference 
of weights after drying at 105 °C for 2-4 h and after burning at 550 °C for 25-40 min. 
The cell biomass in samples as optical density was determined by measurement of 
absorbance at 600 nm using a Hewlett Packard G1130A UV-visible spectrophotometer 
with a sensitivity of 0.0001 level. 
3.3.3 Total Organic Carbon and Total Nitrogen 
Collected liquid samples were filtrated with Whatman 0.2 µm membrane filters 
(Piscataway, NJ) before TOC, ammonia, nitrate, and nitrite analyses.  TOC was 
determined using a Shimadzu Total Organic Carbon Analyzer TOC-VCSH (Shimadzu 
Corporation, Japan).  Ammonia concentrations were measured by using an Accumet 
Ammonia Combination Ion Selective Electrode as followed by manufacturer’s manual 
and ammonia-selective electrode method as described in Standard Methods (104).  
Concentrations of nitrite and nitrate  were measured using a DX-80 Ion Chromatograph 
(IC) (Dionex Corporation, Sunnyvale, CA) equipped with an IonPac AS14A-5µm 
Analytical Column (3 x 150mm) for anion separation.  Detection limits for TOC, 
ammonia, nitrite, and nitrate were 0.5, 0.1, 0.05, and 0.05 mg/L, respectively. 
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3.3.4  Activity Assay for Nonspecific Monooxygenases  
Experiments were conducted similarly as described in degradation tests, except 
using estrogens and cell optical density (OD600) of 0.2.   Samples were collected every 
15 min and divided into two subsets, one for estrogen analysis (5 mL) and  the other one 
for the naphthalene oxidation assay (1 mL).  Concentrations of estrogens were 
determined by GC/MS analysis.  Naphthalene oxidation assays were conducted as 
described by Chu and Alvarez-Cohen (62).  Since naphthol was produced from 
naphthalene oxidation, the naphthalene oxidation rates were measured as naphthol 
production rates.  The produced naphthol quickly interacted with tetrazotized o-
dianisidine solution (freshly made) to form purple naphthol-diazo complex.  The 
quantity of the purple complex was determined by absorbance (at 530 nm) using a 
Hewlett Packard G1130A UV-visible spectrophotometer.  Standard curves were 
constructed by using 1-naphthol over a range of concentrations.  The curves were then 
used to determine the concentrations of naphthol in samples. N. europaea, an ammonia-
oxidizing bacterium, was used as positive controls. 
3.3.5 Activity Assay for Nonspecific Dioxygenases  
The activities of nonspecific dioxygenases in strains KC6, KC7, and KC8 were 
determined by using an indole oxidation assay that was originally developed for 
determining the activity of toluene dioxygenases (63).  Toluene dioxygenase can oxidize 
indole into dark red indoxyl.  The production of indoxyl was monitored using a Hewlett 
Packard G1130A UV-visible spectrophotometer at 400 nm.  Reaction mixtures 
excluding indole were used for negative controls.  An E.coli. strain expressing 
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naphthalene dioxygenase (E. coli. TG1/pBS (Kan) NDO) (105) was used as a positive 
control for the indole oxidation assay.  
3.3.6 DNA Extraction 
FastDNA SPIN kit and FastDNA SPIN kit for soil (MP Biomedicals, LLC, Solon, 
OH) were used to extract genomic DNA of each bacterium (pure) and activated sludge 
samples (mixed) collected from SBRs and WWTPs, respectively.  DNA extractions were 
conducted in accordance with the manufacturer’s instructions with minor modifications; 
after ethanol wash procedures, the DNA complex (silica bound) was washed twice with 
ethanol (80% vol/vol) (78, 106, 107).  DNA concentrations were determined using a 
Hoefer DyNa Quant 300 Fluorometer (Pharmacia Biotech, San Francisco, CA).  
Extracted DNAs were stored at -20 °C to use for molecular works such as real-time PCR 
and real-time-t-RFLP assays. 
3.3.7 Real-time-PCR Assays for Estrogen Degraders, Ammonia-Oxidizing Bacteria, 
and amoA Gene 
Real-time PCR assays were conducted as follows.  The PCR mixture (25 µL of 
total volume) contained 600 nM forward and reverse primers (Table 3.2), 500 nM of 
probe, 12.5 µL of Taq Mastermix (or SYBR Green I for amoA gene), and  2-50 ng of 
DNA template.  The PCR amplification protocol was listed in Table 3.2.  The PCR 
amplification reactions were performed using a Bio-Rad iQ5 Multicolor Real-Time PCR 
Detection System (Bio-Rad Laboratories, Inc., Hercules, CA).  The DNA concentrations 
in samples were determined by comparing to those of standard curves containing known 
DNA concentrations.  Standard curves for quantifying total 16S rRNA gene copies in 
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samples were constructed by using plasmid #931, which carries a Nitrospira partial 16S 
rRNA gene (GenBank accession number AF420301).  Standard curves (ranging from 2.3 
x 101 to 2.3 x 108 copies of the 16S rRNA gene/mL) were generated parallel to the 
sample analysis.  The standard curves for quantifying KC8 and ARI-1 gene copies in 
samples were constructed by using plasmid #931, which carries a strain KC8 partial 16S 
rRNA gene (GenBank accession number DQ066438) or the 16S rRNA gene of ARI-1 
(GenBank accession number AB070237) (24, 27).  Standard curves, ranging from 5.0 x 
102to 5.0 x 108 copies for the KC8 and 1.0x101to 1.0x109 gene copies/mL for ARI-1 
partial 16S rRNA, were generated.  Quantification of AOB was conducted using primers 
(CTO189fA/B and CTO189Fc) and a probe (TMP1) that were previously developed (72, 
108).   Primers (amoA 1f and amoA 1r) and SYBR Green I were used for quantification 
of amoA genes (73, 74).  Standard curves for quantifying AOB gene and amoA gene 
copies were constructed by using plasmid #931, which carries a Nitrosomonas europaea 
16S rRNA (GenBank accession number AB070938).  The plasmid #931 was cloned into 
pCR2.1.  Standard curves, ranging from 1.0x101 to 1.0x109 gene copies of plasmid #931 
and amoA /mL, were generated.   
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Table 3.2.  Primers and probes and PCR protocols used in real-time PCR assay 
Target 
Primer/ 
probe(1)
Sequence(5’-3’)(2)
Tm  
(˚C)(3)
Reference 
1055f 
1392r 
16STaq1115f 
5’-ATGGCTGTCGTCAGCT-3’ 
5’-ACGGGCGGTGTGTAC-3’ 
5’-[6-FAM]-CAACGAGCGC-AACCC-[6-TAMRA]-3’
57.7 
58.9 
62.9 
Bacterial 
16S 
rRNA 
PCR protocol 
95 ˚C for 15min; 45 cycles of  95 °C for 30s, 50 °C for 
1min, and 72 °C for 2min 
(72) 
KC8 f 
KC8 r 
KC8Taq 
 
5’-ACCAGAGATGGTTTCCTTCAGT-3’ 
5’-GCTTGCTGCCCACTGTAGTT-3’ 
5’-[DFAM]ATAGGTGACAGGTGCTGC-
ATGGCTGT[DHH1]-3’ 
62.7 
64.3 
74.0 
 
Strain 
KC8 
PCR protocol 
95 °C for 15min, 40 cycles of  95 °C for 15s, 60 °C for 
30s, 72 °C for 2min 
This study
ARI-1 f 
ARI-1 r 
ARI-1Taq 
 
5’-GCTGTCCGGGCTCATGGAGT-3’ 
5’-CCCGAAGGGAACACCCAATCT-3’ 
5’-[6-FAM]ACCAGCGTTTGACATCCCGCGCTAA- 
[TAMRA-6-FAM]-3’ 
66.6 
64.5 
67.9 
 
ARI-1 
PCR protocol 
95 °C for 15min, 40 cycles of  95 °C for 15s, 63 °C for 
30s, 72 °C for 2min 
This study
CTO189fA/B 
CTO189fC 
RT1r 
TMP1 
 
5’-GGAGRAAAGCAGGGGATCG-3’ 
5’-GGAGGAAAGTAGGGGATCG-3’ 
5’-CGTCCTCTCAGACCARCTACTG-3’ 
5’-[6-FAM]-CAACTAGCTAATCAGRCATCRGCC-
GCTC[TAMRA]-3’ 
63.4 
62.3 
65.5 
69.0 
 
AOB 
PCR protocol 
95 °C for 10min, 40 cycles of  95 °C for 30s, 58 °C 
 for 1min, 72 °C for 1min 
(72, 108, 
109) 
amoA 1f 
amoA 1r 
5’-GGGGTTTCTACTGGTGGT-3’ 
5’-CCCCTCKGSAAAGCCTTCTTC-3’ 
59.9 
65.5 
AmoA 
PCR protocol 
94 °C for 5min, 50 cycles of  94 °C for 30s, 60 °C for 
1min, 72 °C for 30s 
(73, 74, 76, 
109) 
 
1) f = forward primer, r = reverse primer, Taq = TaqMan probe  
2) 6-FAM = 6-carboxyfluorescein, 6-TAMRA = 6-carboxytetramethylrhodamine, 6-DFAM = 6-
carboxyfluorescein, DHH1 = [  ], R=A or G; K=G or T; S=G or C 
3) Tm (˚C), melting temperature was calculated by the oligo calculator of Sigma Genosys 
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3.3.8 Real-time-t-RFLP Assay for Characterizing Microbial Community Structure 
Real-time terminal restriction fragment length polymorphism (real-time-t-RFLP), 
a quantitative fingerprinting method, was used for determining the microbial diversity 
and abundance in samples of SBRs. A region (352 bp long) of the 16S rRNA gene 
sequence was used for the real-time-t-RFLP assay (72, 78, 107). A fluorescence-labeled 
forward primer 16SHex1055f (5’-hexachlorofluorescein-ATGGCTGTCGTCAGCT-3’), 
reverse primer 16S1392r (5’-ACGGGCGGTGTGTAC-3’), and TaqMan probe 16STaq-
1115f (5’-[6-carboxyfluorescein]-CAACGAGCGCAACCC-[6-carboxytetramethylrhod- 
amine]-3’) were used to amplify the target region as follows.  The PCR mixture (25 µl) 
contained 10 x PCR buffer A (2.5 µl), Taq polymerase (1.25 U, Fisher Scientific, Fair 
Lawn, NJ), bovine serum albumin (BSA, 0.5 µg), each of four deoxynucleoside 
triphosphates (DTP, 200 µM), MgCl2 (4.5 mM), forward and reverse primer (600 nM), 
TaqMan probe (250 nM), and DNA (10 ng). The amplification reactions were performed 
using a Bio-Rad iQ5 Multicolor Real-Time PCR Detection System (Bio-Rad 
Laboratories, Inc., Hercules, CA). The PCR conditions were as follows: initial 
denaturation at 95 °C for 10 min, followed by 30 cycles of 95 °C for 30 s, 54 °C for 1 
min, and 72 °C for 2 min, and a final incubation at 4 °C.  The same standard as used in 
3.4.2 was used.  The DNA bands (352 bp) of the PCR products were excised from the 
1.5 % agarose gel in 1 x Tris-acetate-EDTA buffer, and the DNA bands of the expected 
size. The PCR products were purified by using MicroSpin columns (Amersham 
Biosciences, Piscataway, NJ), precipitated by ethanol, and then digested with restriction 
enzyme MspI at 37 °C for 16 h following 20 min of incubation at 70 °C. The digestion 
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mixture (30µl) contained the purified PCR product (60-90 ng), and MspI (10 U).  
The lengths of T-RFs of digested PCR products were determined by using 
Genescan ROX 500 size standards with an ABI Prism 310 genetic analyzer (Applied 
Biosystems, Foster City, Calif.) at DNA Technologies Laboratory in Texas A&M 
University (College Station, TX). The lengths of T-RFs were automatically determined 
by comparison with the internal standards by using the GeneScan software, version 3.1. 
Data acquisition and analysis were done as described by Yu et al. (78, 107). 
 
3.4 Data Analysis 
3.4.1 Quantitative Characterization of Microbial Community Structure Using 
Results Obtained from Real-time-t-RFLP 
The abundance and microbial diversity of samples in SBRs operating under three 
different SRTs were determined simultaneously by using real-time-t-RFLP profiles (78, 
107).  The 16S rRNA gene copy # of the ith T-RF per unit volume (Ci) in a microbial 
community was calculated using the following equation: 
0
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                                                                                            (3-1) 
where, Ci =  16S rRNA gene copy # 
 Co =  initial 16S rRNA gene copy #/ml in the sample 
 jAi =  peak area of the ith T-RF of j length (bases) 
 n =  total number of T-RFs 
 
The relative abundance of the ith T-RF in a microbial community was estimated by the 
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ratio of each peak area to the total peak area, 
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∑
.  T-RFs less than 25 bp long were 
excluded from the data analyses.  The peak area that contributed less than 1% of the total 
area was regarded as background noise and was excluded from the analysis (27). 
3.4.2 Microbial Community Structure: Diversity Indices 
After quantitative analysis of real-time-t-RFLP profiles as described in 3.4.1, 
microbial structural diversities were analyzed with respect to following indices: (i) 
richness (S), (ii) the Shannon-Weaver diversity index (H), (iii) evenness (E), and (iv) the 
reciprocal of Simon’s index (1/D) (99, 110, 111).  The richness (S) of the microbial 
community is determined based on the number of unique T-RFs in a community profile.  
Shannon-Weaver diversity index (H) was calculated using the equation, H = - Σ
(pi)(log2 pi), where pi  is the relative abundance of fragment i.   Evenness (E) was 
estimated by the equation, E = H/(log2[S]).  The reciprocal of Simon’s index (1/D) was 
determined by the equation, 1/D = 1/(Σpi2). 
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4. DEGRADATION OF ESTROGENS BY ESTROGEN-DEGRADING 
ISOLATES* 
 
4.1 Introduction 
Natural (17β-estradiol and estrone) and synthetic (17α-ethinyl estradiol, a major 
ingredient in contraceptives) estrogens in treated wastewater are considered to contribute 
the most to the estrogenic activity (19, 20) since estrogens have three orders of 
magnitude higher estrogenic potencies than other identified EDCs in wastewater.  
Estrogens produced naturally by humans and animals or used for personal care are 
excreted in urine and feces as inactive polar conjugates.  The conjugates can be 
converted back to unconjugated estrogens (active forms) by bacterial enzymes in the raw 
wastewater and during the wastewater treatment processes.  Estrogens survived from the 
treatment processes are subsequently released into the environment through effluent.  
Thus, treated wastewater is considered one of the most likely estrogenic sources released 
into the environment.  Numerous laboratory and field studies have focused on the fate of 
estrogens in wastewater treatment plants in the past decades (see review (9, 21, 50-53, 
55, 112)).  The estrogen concentrations in the effluent of WWTPs ranges 0.1-1 ng/L (22, 
113).  
____________ 
* Reprinted with permission from “17β-estradiol-degrading bacteria isolated from 
activated sludge” by Chang-Ping Yu, Hyungkeun Roh, and Kung-Hui Chu, 2007. 
Environmental Science & Technology, 41, 486-492, Copyright [2007] by American 
Chemical Society. 
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Removal of estrogens by WWTPs was observed to different degrees − ranging from 
19-94 % for estrone, 76-92 % for 17β-estradiol, and 83-87 % for 17α-ethinyl estradiol 
(9). 
 While estrogens were suggested to be mainly removed via biodegradation 
during wastewater treatment, little is known about the microorganisms responsible for 
estrogen degradation.  Early studies reported that several human intestinal bacteria and 
oral microorganisms are capable of converting estradiol to estrone and vice versa (114-
116).   Shi et al. (23) reported that biodegradation of estrogens by nitrified activated 
sludge and Nitrosomonas europaea and suggested that other heterotrophic bacteria 
might be involved in 17β-estradiol degradation.  Recently, Fujii et al. (24) isolated the 
first 17β-estradiol-degrading bacterium, Novosphingobium species (ARI-1), from 
activated sludge.   Lately, six estrogen-degrading isolates (four Rhodococcus strains, an 
Achromobacter strain, a Ralstonia strain) from activated sludge were reported by 
Yoshimoto et al. (25) and Weber et al.(26).   
 Based on the hypothesis that estrogen-degrading cultures are widespread in 
activated sludge, fourteen phylogenetically diverse 17β-estradiol-degrading cultures 
(strains KC1 through KC14) were isolated from activated sludge in this laboratory (27).  
Results of 17β-estradiol degradation tests indicated that all fourteen isolates could 
convert 17β-estradiol to estrone within 7 d.  However, only three strains (strains KC6, 
KC7, and KC8) were capable of degrading estrone.  Based on the extent of estrogen 
being transformed and the estrogenicity of metabolites and/or end-products of estrogen 
degradation, three different degradation patterns (Patterns A, B and C) were observed. 
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Isolates in the group of Pattern A were capable of degrading 17β-estradiol but not 
estrone within 7 d.  One-to-one stoichiometric conversion of 17β-estradiol to estrone was 
observed and the sum of molar concentrations of 17β-estradiol and estrone remained 
unchanged for 7 d.  Complete transformation of 17β-estradiol to estrone occurred rapidly 
within 1 d (Figure 4.1) or slowly within 7 d.  However, as the concentrations of 17β-
estradiol decreased, the concentrations of estrone increased and accumulated over the 
tested period, suggesting that estrone was a metabolite during 17β-estradiol 
transformation.   Strains KC1 through KC5 and KC14 exhibited degradation Pattern A. 
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Figure 4.1  Estrogen degradation Pattern A. 17β-Estradiol was completely converted to 
estrone that was later accumulated in liquid medium.  Solid diamonds (17β-estradiol) 
and open squares (estrone).  The bars indicate the ranges of duplicate experiments (27). 
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Isolates in the group of Pattern B exhibited the ability to transform estrone within 
7 d.  In Pattern B, the transformation of 17β-estradiol to estrone occurred much slower 
compared to those observed in Pattern A.  After the initial accumulation of estrone 
during 17β-estradiol degradation, the concentrations of estrone began to decline after 5 d.  
Strains KC6 and KC7 showed this degradation trend (Figure 4.2).   Their abilities to 
degrade estrone were consistent with results observed in the 7-d estrone degradation 
tests.  Approximately 21 ± 5% and 27 ± 4% of estrone were degraded by strains KC6 
and KC 7, respectively. Degradation of 17β-estradiol and estrone were much improved 
in Pattern C.  17β-estradiol was rapidly transformed into non-estrogenic compounds 
within 7 d.  Only strain KC8 showed this degradation pattern (Figure 4.3).  Interestingly, 
an increase of estrone concentration was observed in the first 20 min of 17β-estradiol 
degradation.  Within 24 h, 17β-estradiol was no longer detected, and estrone was 
measured at an average concentration of 48µg/L.  No estrogenic activity was observed in 
day-5 and day-7 samples as determined by YES assays, suggesting the absence of 
estrogenic metabolites and/or end products from 17β-estradiol degradation.   
The overall results indicated that strain KC8 could rapidly degrade 17β-estradiol 
and estrone into non-estrogenic compounds.  Three isolates (strains KC6, KC7, and KC8) 
that showed an ability to degrade estrone were further characterized in this section.    
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Figure 4.2.   Estrogen degradation Pattern B. 17β-Estradiol and estrone were degraded at 
slower rates, leading reduction of total estrogenic activity and estrogen concentrations.  
Solid diamonds (17β-estradiol) and open squares (estrone).  The bars indicate the ranges 
of duplicate experiments (27).  
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Figure 4.3   Estrogen degradation Pattern C. 17β-Estradiol and estrone were degraded 
rapidly into none estrogenic compounds in 7 d.   Solid diamonds (17β-estradiol), and 
open squares (estrone). The bars indicate the ranges of duplicate experiments (27). 
 
 
4.2 Results and Discussion 
4.2.1 Estrogen Degradation 
While the ability to transform 17β-estradiol to estrone was observed in all 
fourteen isolates, the ability to degrade estrone was observed only in three strains 
(strains KC6, KC7, and KC8) (27).   The experiments for estrogen degradation by strains 
KC6 and KC7 were conducted with a different initial biomass (OD600=0.5).  The trends 
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of 17β-estradiol degradation by strains KC6, KC7, and KC8 (data not shown) were very 
similar to Pattern B and C, respectively, as described in Yu et al. (27).  Along with the 
production and/or accumulation of estrone during 17β-estradiol degradation, three points 
could be made.  First, the ability to oxidize the secondary alcohol on the C17 position of 
17β-estradiol to ketone might be a common feature among these isolates.  Second, 
estrone was a major metabolite during 17β-estradiol biodegradation.  Third, the step to 
degrade estrone might be the rate-limiting step for converting estrogens (17β-estradiol 
and estrone) to non-estrogenic metabolites or end products.  These suggestions were 
supported by many previous studies (9, 52, 112, 117).   A good removal of 17β-estradiol 
but a less satisfactory removal of estrone by wastewater treatment plants was reported (9, 
52, 112, 117).  In some cases, much higher concentrations of estrone were observed in 
effluents than in influents of wastewater treatment plants (9, 117).   Laboratory batch 
tests using 14C-labeled estrogens revealed a better removal for 17β-estradiol than for 
estrone (21).   
4.2.2 Ability to Use 17β-estradiol as a Sole Carbon Source 
After 25 d of incubation, the amended 17β-estradiol was depleted in flasks 
inoculated with strain KC8 (Figure 4.4).  Protein contents in the flasks increased from 6 
mg/L to 63 mg/L.   The average growth yield was estimated to be 0.23 mg of protein/mg 
of 17β-estradiol.  The doubling time of strain KC 8 using 17β-estradiol was estimated to 
be 27 h.  However, no significant degradation of 17β-estradiol or increase in protein 
content was observed for strain KC6 (Figure 4.5) or KC7 (Figure 4.6) over 36 d, 
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suggesting that strains KC6 and KC7 were not able to use 17β-estradiol as a sole carbon 
source for growth.   
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Figure 4.4  Degradation of 17β-estradiol and growth of strain KC8 in NMS-estrogen 
medium. The growth was monitored by measuring the protein concentration of the 
cultures. Solid diamonds (17β-estradiol), open diamonds (protein content, with 17β-
estradiol), and open circles (protein content, without 17β-estradiol (growth controls)).  
The bars indicate the ranges of duplicate experiments (27). 
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Figure 4.5  Degradation of 17β-estradiol (a) and growth of strain KC6 (b) in NMS-
estrogen medium. The growth was monitored by measuring the protein concentration of 
the cultures. Solid diamonds (17β-estradiol), solid squares (protein content, with 17β-
estradiol), and open circles (protein content, without 17β-estradiol (growth controls)).  
The bars indicate the ranges of duplicate experiments. 
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Figure 4.6  Degradation of 17β-estradiol (a) and growth of strain KC7 (b) in NMS-
estrogen medium. The growth was monitored by measuring the protein concentration of 
the cultures. Solid diamonds (17β-estradiol), solid squares (protein content, with 17β-
estradiol), and open circles (protein content, without 17β-estradiol (growth controls)).  
The bars indicate the ranges of duplicate experiments. 
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The different degradation abilities of these isolates might be explained by two 
possible degradation mechanisms, non-growth linked (cometabolic) and/or growth-
linked (metabolic) reactions.  Cometabolic reactions ─ non-beneficial reactions 
catalyzed by existing enzymes that are designed specific for other purposes ─ might be 
responsible for estrogen degradation resulting in degradation Pattern A.  This hypothesis 
was supported by several lines of evidence observed in this study.  Strains showing the 
ability to convert 17β-estradiol to estrone in a rapid and stoichiometric matter (Pattern 
A1) strongly suggested that degradation of 17β-estradiol might be due to cometabolic 
reactions using enzyme(s) already present in these strains.   The slower transformation of 
17β-estradiol to estrone observed in degradation pattern A2 might be due to a weaker 
affinity of enzyme to 17β-estradiol.   Furthermore, several attempts to grow these strains 
with 17β-estrodial as a sole carbon source were unsuccessful (data not shown).  
These observations of partial removal of estrone (20-30 % in 7 d) were 
insufficient to indicate which degradation mechanism was responsible for estrogen 
degradation in strains KC6 and KC7.   A recent study reported estrone was converted to 
17α-estradiol under nitrate-reducing conditions (118).  In our 17β-estradiol and estrone 
degradation tests, no 17α-estradiol was detected.  Yet, more tests conducted with a 
longer experimental duration are needed to clearly illustrate the biodegradation of 
estrone.   Nonetheless, the results of growth tests for strains KC6 and KC7 suggested 
that estrogens were most likely degraded by strains KC6 and KC7 via cometabolic 
reactions.   
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Growth-linked, metabolic reactions ─ commonly involved in energy or carbon 
sources for microbial growth ─ might explain the degradation Pattern C shown by strain 
KC 8.  This hypothesis was supported by the results of growth tests.  As shown in Figure 
4.4, strain KC 8 was capable of growing in the acetone-free NMS-estrogen medium 
(with 20 mg of 17β-estradiol) for two weeks, with an average growth yield of 0.23 mg of 
protein/mg of 17β-estradiol and a doubling time of 27 h.    
 The implication of the widespread ability to transform 17β-estradiol to estrone 
among fourteen phylogenetically diverse isolates is important, since the total estrogenic 
activity is readily reduced.  Interestingly, only three strains were found to degrade 
estrone.  Since estrone still has a relatively high estrogenic potency (119) and higher 
average effluent concentrations (about 3.5 times higher than 17β-estradiol) (9, 117), 
these results suggested that effective removal of estrone in wastewater is probably the 
key to reduce total estrogenicity in the effluent.   Three strains (KC6, KC7, and KC8) 
exhibited degradation of estrone and thus hold a great promise for completely 
mineralizing estrogens. 
4.2.3 Enzyme Activity of Nonspecific Oxygenases in Strains KC6, KC7, and KC8 
Positive results of naphthalene oxidation assays were observed for all three 
strains, suggesting the presence of nonspecific monooxygenase enzymes.  Negative 
results of indole oxidation assays were observed for strains KC6, KC7, and KC8, 
implicating that these strains might not have nonspecific dioxygenase enzymes.    
The results of enzymatic characterization showed that strain KC8 exhibited 
nonspecific monooxygenase activity but not dioxygenase activity.  Similar findings were 
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also obtained for strains KC6 and KC7.   Nonspecific monooxygenases are known to be 
responsible for metabolic and/or cometabolic reactions of a wide range of organics (120, 
121).  Shi et al. suggested that ammonia monooxygenase (a nonspecific monooxygenase 
enzyme produced by ammonia-oxidizing bacteria) might be responsible for estrogen 
degradation (23).  In this study, it is likely that nonspecific monooxygenase enzymes 
were responsible for estrogen degradation by strain KC8.  However, more experiments 
are needed to test this hypothesis. 
 53
5. CHARACTERIZATION OF SPHINGOMONAS STRAIN KC8, AN  
ESTRADIOL- UTILIZING BACTERIUM 
 
5.1 Introduction 
Conventional WWTPs are designed to remove bulk organics not micropollutants 
like estrogens.  As a result, estrogens remaining in the treated wastewater are 
subsequently released into the environment via effluent discharge.  Not surprisingly, 
estrogens are detected in effluent, rivers and even in drinking water (18, 19, 122-124).   
Previous studies have suggested that biodegradation is an important removal 
mechanism for estrogens during wastewater treatment processes (17, 112, 117), despite 
incomplete removal of estrogen in WWTPs.   Layton et al. reported the first evidence of 
estrogen mineralization in activated sludge samples (21).  Since then, several estrogen-
degrading bacteria were isolated from activated sludge, including Novosphingobium 
tardaugens (ARI-1) (24), Rhodococcus zopfii and Rhodococcus equi (25),  and 
Achromobacter xylosoxidans and Ralstonia sp. (26), and strains KC1 through KC14 (27).  
Nevertheless, the degradation kinetics of estrogens for the known estrogen-degrading 
isolates have not been investigated.  The knowledge of estrogen utilization kinetics is 
essential for determining the fate of estrogen in wastewater and for formulating effective 
biological treatment processes for estrogen removal. 
Strain KC8 has the potential to be used for effective estrogen removal because it 
can (i) degrade both 17β-estradiol and estrone (within 3 d) to non-estrogenic compounds, 
(ii) use 17β-estradiol as a sole carbon source, and (iii) grow rapidly on complex nutrients 
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(27).  However, one potential limitation is that low levels (ng/L) of estrogens in 
wastewater might not be sufficient to support the growth of strain KC8.  Given that there 
are a wide range of organics in wastewater, it would be important to know whether strain 
KC8 can grow on other wastewater organics while retaining its degradation ability 
toward estrogens.  Furthermore, strain KC8 exhibited the nonspecific monooxygenases 
activity (i.e., oxidizing naphthalene to naphthols), but not nonspecific dioxygenases 
activity (27).  However, it was unclear if the nonspecific oxygenases were involved in 
estrogen degradation and/or capable of degrading other emerging micropollutants in 
wastewater. 
The objective of this study is to further characterize strain KC8 with respect to its 
potential to be used for effective estrogen removal in engineered biological systems.  
Experiments in this study were designed to address the following questions: (i) Does 
strain KC8 have an ability to degrade and/or utilize macro- and micro-pollutants in 
wastewater?  (ii) Can strain KC8 grow on complex nutrients and retain its ability to 
degrade 17β-estradiol and estrone? (iii) What are the utilization kinetic parameters for 
estrogens (17β-estradiol and estrone)? and (iv) Can strain KC8 degrade and/or utilize 
male hormone like testosterone? If yes, what is the utilization/degradation kinetics? 
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5.2 Results 
5.2.1 Ability to Utilize and/or Degrade Macro- and Micro-pollutants in Wastewater 
Results of substrate degradation tests showed that strain KC8 could degrade 
testosterone, but not triclosan or bisphenol A.  Approximately 95 % of added 
testosterone was degraded within 1 d (Figure 5.1a).  Strain KC8 could also grow on 
testosterone.   After 25 d of incubation, the biomass of strain KC8 increased twelve 
times, from 4 to 48 mg-protein/L (Figure 5.1b).  The average growth yield was estimated 
to be 0.33 mg-protein/mg-testosterone and the doubling time was estimated to be 61 h. 
Strain KC8 was able to utilize all organic substrates tested to support its growth, 
except for phenol.  The biomass of strain KC8 (expressed as protein content) increased 
from 9 to 45 mg/L for glucose in 4 d; from 9 to 38 mg/L for sodium succinate in 2.5 d; 
and from 11 to 47 mg/L for sodium acetate in 5 d (Figure 5.2).  Assuming each substrate 
was completely depleted when the maximum optical densities were reached and the 
cellular decay was insignificant, the average cellular yields were estimated to range from 
0.04 to 0.4 mg-VSS/mg-BODL.  The doubling times were estimated ranging from 20 to 
29 h when using different substrates (Table 5.1). 
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Figure 5.1 Degradation of testosterone by strain KC8 over time (a) and utilization of 
testosterone as a growth substrate by strain KC8 in NMS medium (b). Solid diamonds 
(testosterone). Open circles (controls (a)), open diamonds (growth of strain KC8 
expressed as protein content (b)), and open circles (protein content of strain KC8 in 
controls (b))).  The bars represent the ranges of duplicate experiments. 
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Figure 5.2 Cell growth (as protein content) of strain KC8 over time by using organics as 
a growth substrate.  Strain KC8 utilized glucose, sodium succinate, and sodium acetate, 
but not phenol, as a sole carbon source.  Initial protein contents were around 14 mg/L.  
Solid squares (glucose), solid triangles (sodium succinate), solid circles (sodium acetate), 
and open squares (phenol), “X” (negative controls).  The bars indicate the ranges of 
duplicate data points. 
 
 
 
 
 
 58
Table 5.1  Substrate utilization kinetic parameters of strain KC8 
 
Substrate 
 
 
 
Parameters 
17β-est-
radiol Estrone
Testos-
terone Glucose
Sodium 
succinate
Sodium 
acetate 
Typical value 
for activated 
sludge 
processa
mq  
 (mg-substrate/ 
mg-protein/d) 
0.37 ± 
0.02 
0.50  ± 
0.02 
0.17  ± 
0.01 _ _ _ _ 
mq  
(mg-BODL/mg -
protein/d)b
1.00 ± 
0.05 
1.35  ± 
0.05 
0.48  ± 
0.03 _ _ _ 52-70 
d
mK  
(mg-substrate/ 
L) 
1.9 ± 
0.2 
2.7 ± 
0.3 
2.4  ± 
0.4 _ _ _ _ 
mK  
(mg-BODL/L)b
5.1  ± 
0.5 
7.3  ± 
0.8 
7.0  ± 
1.2 _ _ _ >10 
Y  
(g-VSS/g-
BODL) b,d
0.22c  _ 0.30 0.05 0.04 0.4 0.42-0.49 
Doubling time 
(hr) 27
c  _ 61 20 24 29 _ 
 
mq = maximum specific substrate utilization rate,  = half velocity constants mK
Y= yield coefficient       -   = not available 
a  data from Rittmann and McCarty (64)
b  1 mg-substrate/L = 2.7, 2.8, 1.1, 0.6, or 0.5 mg-BODL /L for 17β-estradiol, testosterone, 
glucose, sodium succinate, and sodium acetate, respectively, based on their theoretical 
oxygen demand.  
c  data from Yu et al.(27).      
d  The reported  values range from 20-27  mg-BODmq L /mg-VSS/d.  For comparison, the unit of  
these values was converted to mg-BODL / mg -protein/d.  The conversion was done by using  
VSS (g) = 2.6 x protein (g) as measured in the laboratory.  
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5.2.2 Estrogen-Testosterone Utilization Kinetic Parameters 
The Monod equation described estrogens and testosterone degradation kinetics 
well (Figure 5.3).   The maximum specific substrate utilization rate ( ) were estimated 
to be 0.37 ± 0.02, 0.50 ± 0.02, and 0.17 ± 0.01 mg-substrate/mg-protein/d for 17β-
estradiol, estrone, and testosterone, respectively.  The estimated half velocity constants 
( ) are 1.9 ± 0.2  mg-17β-estradiol/L, 2.7 ± 0.3 mg-estrone/L, and 2.4 ± 0.4  mg-
testosterone/L (Table 5.1).  Changes of cellular protein content were negligible (less than 
5 %) during the kinetic experiments.  
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Figure 5.3   Monod degradation kinetic of 17β-estradiol (a), estrone (b), and testosterone 
(c) by strain KC8.   The changes of biomass concentrations were negligible within 2 h 
(less than 5 %).  Solid symbols represent experimental data and the dash line represents 
fitted Monod kinetic curve.  The bars indicate the ranges of duplicate data points.  
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Figure 5.3   Continued.  
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5.2.3 Effects of Complex Nutrients on Estrogen Degradability 
While Novosphingobium tardaugens (ARI-1) could degrade estrogens when  
grown on nutrient-rich medium containing estrogen (Figure 5.4d), ARI-1 lost its 
degradability toward estrone after growth on nutrient-rich, estrogen free medium for 7 d 
(Figure 5.4b) (31).  Similar experiments were conducted to examine the effects of 
complex nutrients on estrogen degradability of strain KC8.  Strain KC8 retained its 
ability to degrade 17β-estradiol and estrone after growth on R2A agar plates without 
17β-estradiol for 15 d (Figure 5.4a).  Approximately 62 % of the initial 17β-estradiol 
was degraded.  Meanwhile, estrone concentrations increased in the first 30 h and then 
decreased to non-detectable level after 5 d.  The results were different from those 
obtained from the strain KC8 grown with a complex nutrient medium containing 17β-
estradiol (Figure 5.4c), where 17β-estradiol was rapidly degraded to near zero within 24 
h.   
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Figure 5.4  Effects on 17β-estradiol degradation of strain KC8 (a) and ARI-1 (b) after 
growth in complex nutrient medium over a period of time.  Biodegradation of 17β-
estradiol by strains KC8 (c) and ARI-1 (d) when 17β-estradiol presented in the complex 
nutrient medium.  Solid diamonds (17β-estradiol by KC8), open diamonds (estrone by 
KC8), solid squares (17β-estradiol by ARI-1), open squares (estrone by ARI-1)and open 
circles (controls).  The bars represent the ranges of duplicate data points. Figure (b) and 
(d) were from Yang et al. (31).  
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Figure 5.4  Continued.  
 
 
 
 64
5.3 Discussion 
The 17β-estradiol-utilizing bacterium Sphingomonas strain KC8 was 
characterized from many different aspects.  One important finding of this study was that 
strain KC8 could degrade and further utilize testosterone as a growth substrate.   
Testosterone is a micropollutant that co-exists with estrogens in wastewater.   
Testosterone has been detected in 2.8 % of 139 US rivers with a medium concentration 
of 116 ng/L (125).  Such an ability of strain KC8 is favorable, since strain KC8 would 
remove testosterone and estrogens (17β-estradiol and estrone) simultaneously from 
wastewater.           
The utilization kinetics of estrogens and testosterone by strain KC8 is an 
important factor to evaluate whether strain KC 8 can be applied practically for effective 
estrogen and testosterone removal in biological systems.  For easy comparison, the units 
of utilization kinetic parameters were converted to BODL basis (see Table 5.1).  The  
values (5.1-7.3 mg-BOD
mK
L/L) for strain KC8 are smaller than those for heterotrophs in 
activated sludge ( > 10 mg-BODmK L /L).  The measured  values (0.5-1.4 mg-BODmq L 
/mg-protein/d) are also smaller than the typical value for heterotrophs in activated sludge 
(reported as 20-27 mg-BODL/mg-VSS/d (64) or 52-70 mg-BODL/mg-protein/d as shown 
in Table 1).  Based on these kinetic values and the small growth yield of strain KC8 
(0.23 mg of protein/mg of 17β-estradiol) (27), an impractical long solid retention time 
(SRT) will be required for completely mixed activate sludge systems to remove 
estrogens down to ng/L levels 
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The need of the long SRTs might be overcome if strain KC8 can grow rapidly on 
other common organic constituents (macro-pollutants like glucose and other organics) in 
wastewater without losing its degradation ability toward estrogenic compounds.  To 
investigate this aspect, strain KC8 was examined for its ability to grow on glucose, 
sodium succinate, or sodium acetate.  Glucose is a representative carbohydrate in 
wastewater, with a typical influent concentration 104-fold times higher than the 
concentrations of estrogens in wastewater.  Sodium succinate and sodium acetate are 
compounds which are able to be involved in TCA (tricarboxylic acid) cycle responsible 
for generating energy and carbon sources in many microorganisms.  As shown in Figure 
5.2 and Table 5.1, strain KC8 can utilize these three organics with short doubling times 
ranging from 20 to 29 h, suggesting that strain KC8 can thrive in existing activated 
sludge systems.  This hypothesis can be easily tested by measuring the abundance of 
stain KC8 in various biological wastewater treatment processes.   
Effective removal of estrone might be a key to reduce total estrogenicity  in 
wastewater (27), as many field studies reported elevated estrone in treated wastewater 
and not many known estrogen-degrading isolates can degrade estrone effectively.  To 
our knowledge, both strains ARI-1 and KC8 could degrade 17β-estradiol and estrone 
rapidly when grown on complex nutrients with 17β-estradiol ((Figures 5.4c and 5.4d).  A 
previous study has shown that Novosphingobium tardaugens ARI-1 (a known estrogen 
degrader) was unable to retain its degradation ability toward estrone after growing on 
nutrient-rich, estrogen-free medium for 7 d (31) (Figure 5.4b).   Unlike strain ARI-1, 
strain KC8 was still able to degrade 17β-estradiol without accumulation of estrone, when 
 66
17β-estradiol was removed from the growth medium for 15 d (Figure 5.4a).  These 
results implied that strain KC8 would play an important role in degrading estrogen to 
non-estrogenic metabolites/end product even in wastewater with low, and/or fluctuating 
concentrations of estrogens. 
Little is known about the biodegradation pathway of estrogen. The positive 
results from the naphthalene oxidation tests suggest that nonspecific monooxygenases 
might be involved in estrogen degradation by strain KC8 in Section 4 (27).  In addition, 
strain KC8 was able to degrade and utilize testosterone and estrogens in this study.  As a 
meta-cleavage enzyme has been identified as a key enzyme for the testosterone 
degradation by a Gram-negative bacterium Comamonas testosteroni TA441 (61, 126), it 
is possible that nonspecific monooxygenases and/or meta-cleavage enzyme is involved 
in the degradation of estrogens by strain KC8.   Further studies are needed to identify the 
degradation pathway of estrogen degradation by strain KC8. 
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6. EFFECTS OF SOLIDS RETENTION TIMES ON ESTROGEN-DEGRADING  
MICROBIAL COMMUNITY STRUCTURE IN BIOREACTORS 
 
6.1 Introduction 
The presence of endocrine disrupting compounds (EDCs) in the environment is of 
a concern due to their ability to cause reproductive abnormalities in wildlife (1, 5, 9).  
Incomplete removal of estrogens by wastewater treatment plants (WWTPs) contributes to 
environmental EDCs through the discharge of estrogen-containing effluent (18, 19, 123, 
124). Therefore, improving estrogen removal by WWTPs is essential to minimize 
estrogens entering the environment.   
Solid retention time (SRT) is an important operating parameter used to create 
unique microbial communities capable of removing organic (BOD) and/or nitrogen during 
biological wastewater treatment.  A short SRT (from 5 to 10 d) is commonly used to 
achieve high BOD removal; while a longer SRT (10 to 20 d) is required for slow growing 
microorganisms (64, 127, 128) like nitrifying microorganisms during nitrification.  
Biodegradation of estrogen by both pure ammonia-oxidizing bacteria and by nitrifying 
activated sludge have been recently reported (23, 129, 130).  Additionally, several 
heterotrophic estrogen-degrading microorganisms have been recently isolated from 
nitrifying activated sludge (21, 24-27).  Even though many studies suggested that a long 
SRT is needed for enhanced estrogen (124, 127, 131, 132), no correlations between SRTs 
and estrogen removals have been established and/or verified.   
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The objective of this study is to examine whether one can enhance estrogen 
removal by controlling SRT in bioreactors.  As a change in SRT will subsequently change 
function and structure of the microbial community in bioreactors, this study examined the 
changes of estrogen-degrading microbial community in lab-scale sequencing batch 
reactors (SBRs) operated under different SRTs (5, 10, and 20d).   An effective estrogen 
degrader, Sphingonmonas strain KC8 reported from our previously study (27), was used 
as a model estrogen degrader in the SBRs to examine for its application potential for 
estrogen removal.  The strain KC8 can degrade estrogen into non-estrogenic products.  
The performances of SBRs in terms of estrogen removal, BOD removal, and nitrification, 
were evaluated. Molecular techniques were developed and applied to quantify the total 
microbial population, estrogen degraders (strain KC8, ARI-1, ammonia oxidizing bacteria 
(AOB), and amoA gene) in lab-scale SBRs and three full-scale WWTPs.  Effects of SRT 
on microbial community structure in SBRs were examined using quantitative 
fingerprinting assay, real-time-t-RFLP (real time terminal restriction fragment 
polymorphism) (78). 
 
6.2 Results 
6.2.1 Validation of Real-Time PCR Assays 
 Real-time PCR assay for strain KC8 was validated using axenic KC8, mixed 
culture of SBR-5d, and thirteen other estrogen degraders (strains KC1 through KC7 and 
KC9 through KC14).  A linear relationship (r2 = 0.998) was observed between the Ct 
values and the amounts of DNA of strain KC8 in the templates, ranging from 0.2 ng to 
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100 ng (APPENDIX A-1).  Similarly, a linear relationship (r2 = 0.999) was observed for 
the mixed culture in the templates (ranging 0.5 ng to 150 ng) (APPENDIX A-2).  No 
signals (Ct > 40 cycles) were detected when the assay was challenged against all thirteen 
other 17β-estradiol-degrading bacteria.  Validation of real-time PCR assay for ARI-1 
was conducted similarly using known amounts of DNA of strain ARI-1.  A linear range 
(r2 = 0.994) for templates containing 0.25 ng to 250 ng of DNA of strain ARI-1 was 
observed.   For DNA of SBR mixed culture, the linear range was from 0.25 ng to 250 ng 
(r2 = 0.993) (APPENDIX B).  Again, no signals (Ct > 40 cycles) were detected when the 
real-time PCR assay for ARI-1 was challenged against eight KC strains (KC1 through 
KC2 and KC9 through KC14). 
6.2.2 Performance of Bioreactors 
 The initial biomass concentrations (expressed as MLVSS) in all three SBRs 
decreased rapidly during the startup phase and then reached steady state after the 
reactors were operated for two times of each operating SRT.  The steady biomass 
concentrations were 650, 750, and 905 mg/L for SBR-5d, SBR-10d, and SBR-20d, 
respectively (Figures 6.1A(a), 6.1B(a), and 6.1C(a)).   After the first cycle of operation, 
TOC removal rapidly reached 87 % for SBR-5d, 89 % for SBR-10d, and 92 % for SBR-
20d (Figures 6.1A(b), 6.1B(b), and 6.1C(b)).  Initial ammonia concentration (25 mg/L) 
was reduced to less than 1 mg/L in effluent in all three SBRs.  The steady ammonia 
removals (after operating for 2 times of each SRT) were 91-99 % for SBR-5d, 96-99 % 
for SBR-10d, and 97-99 % for SBR-20d (Figures 6.1A(c), 6.1B(c), and 6.1C(c)).  No 
nitrite was detected in influent and effluent.   Influent concentrations of nitrate ranged  
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Fig 6.1A.                                                                   Fig 6.1B. 
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Figure 6.1.  MLVSS (a), TOC (b), ammonia (c), and nitrate (d) concentrations in SBRs 
under 5d (Fig 6.1A), 10d (Fig 6.1B), and 20d (Fig 6.1C) of SRT.  Solid triangles for 
(MLVSS). Open diamonds (influent) and solid squares (effluent) for TOC, nitrate and 
ammonia concentration.  
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Figure 6.1.  Continued.  
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from 1 to 2 mg/L.  The range of nitrate concentrations in the effluent was 6.0-17.0 mg/L 
for SBR-5d, 7-18 mg/L for SBR-10d, and 6-17 mg/L for SBR-20d  (Figures 6.1A(d), 
6.1B(d), and 6.1C(d)). 
 The overall removals of 17β-estradiol were more than 98.7 % for all three SBRs 
(details are available in APPENDIX B). The fraction of estrogen removed due to 
sorption onto biomass was estimated using sorbed fraction = (MLSS x Kd) / (1 + MLSS 
x Kd) and a sorption coefficient (Kd = 476 l/kg) (133).  The percentages of 17β-estradiol 
sorbed onto biomass were estimated to be 32 % in SBR-5d, 37 % in SBR-10d, and 42 % 
in SBR-20d.  Accordingly, the percentages of 17β-estradiol removed due to 
biodegradation were 67 % for SBR-5d, 62 % for SBR-10d, and 57 % for SBR-20d.  In 
contrast to results from previous studies (124, 127, 131, 132), our results suggested that 
a shorter SRT (5d) was more favorable for 17β-estradiol biodegradation than longer 
SRTs (10 and 20d) (Figure 6.2). 
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Figure 6.2.  17β-estradiol removals for 3 x SRT in the bioreactors operating under 5, 10, 
and 20d of SRT. 17β-estradiol removals by sorption (small grid) and by biodegradation 
(open). Error bars indicate the standard deviation of results of 17β-estradiol removals. 
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6.2.3 Microbial Community Structure in Sequencing Batch Reactors 
 Changes in microbial community structure in three SBRs were observed (Figure 
6.3).  The species richness (S) of microbial community structures in three SBRs were 
observed − the number of ribotypes (i.e., terminal-restricted fragments T-RFs) increased 
from nine to twelve as STR increased from 5 to 20 d.   Among these ribotypes, six T-
RFs (i.e., T-RF= 84 bp, 104 bp, 106 bp, 305 bp, 326 bp, and 328 bp) appeared in the 
microbial communities of all three SBRs. Theoretical T-RFs of known estrogen 
degraders by using in silico analysis with a restriction enzyme MspI were shown in 
Table 6.1. Based on the values of evenness (E), there was not much difference in the 
evenness of microbial communities in three SBRs.  However, the values of Shannon-
Weaver diversity index (H) and the reciprocal of Simon’s index (1/D) increased as SRT 
increased (Table 6.2).  
 
 75
Figure 6.3A   
SBR-5d
1.00E+06
1.00E+07
1.00E+08
26 27 39 84 89 90 98 99 10
3
10
4
10
6
17
4
18
7
21
7
24
6
30
5
32
6
32
8
32
9
T-RF
co
pi
es
 #
/m
L
 
Figure 6.3B 
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Figure 6.3C 
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Figure 6.3  Real-time-t-RFLP profiles in SBRs after operating three times of SRT.  Real-
time-t-RFLP profiles in samples of SBRs operating under 5d (Fig 6.3A), 10d (Fig 6.3B), 
and 20d (Fig 6.3C) of SRT. Below tables contained the list of the known estrogen 
degraders which might contribute to the T-RFs based on restriction enzyme (MspI) 
analysis 
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Table 6.1  Theoretical T-RFs of known estrogen degraders by using in silico analysis  
 with a restriction enzyme MspI   
Theoretical T-RFs (bp) Known estrogen degraders to be contributed to T-RFs 
84 KC3 
99 Achromobacter xylosoxidans, Ralstonia picketii 
104 KC2, 6-12, 14, ARI-1 
106 AOB, KC4-5, Rhodococcus zofii, Rhodococcus equi 
187 KC1 
 
 
Table 6.2  Analysis of microbial community structure in SBRs 
SRT Sample S (1) H (2) E (3) 1/D (4) 
5 d 
1 x SRT (5d) 
2 x SRT (10d) 
3 x SRT (15d) 
8 
10 
9 
1.939 
2.049 
2.015 
0.646 
0.617 
0.636 
6.109 
6.458 
6.674 
10 d 
1 x SRT (10d) 
2 x SRT (20d) 
3 x SRT (30d) 
11 
10 
10 
2.180 
2.037 
2.082 
0.630 
0.613 
0.627 
7.644 
6.278 
7.026 
20 d 
1 x SRT (20d) 
2 x SRT (40d) 
3 x SRT (60d) 
14 
12 
12 
2.511 
2.349 
2.386 
0.659 
0.655 
0.665 
11.276 
9.300 
10.155 
(1) S : richness  
(2) H: Shannon-Weaver Index 
(3) E : Evenness 
(4) 1/D : Reciprocal of Simpson’s Index 
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6.2.4 Estrogen Degrading Bacteria in Sequencing Batch Reactors 
The relative abundance of estrogen degrading bacteria (strains KC8, ARI-1, and 
N. europaea) in three SBRs was estimated.   The initial concentrations of total bacteria 
in three SBRs were 4.1-17.1 x108 copies of 16S rRNA gene /mL (Figure 6.4).   The 
concentrations of total bacteria decreased rapidly during the startup phase in each 
bioreactor.  After three times of SRTs, the total bacterial concentration reached steady, 
approximately 8.4E+07, 2.5E+08, and 4.1E+08 copies of 16SrRNA/mL for SBR-5d, 
SBR-10d, and SBR-20d, respectively.  Similar trend was observed for strain KC8, from 
initial concentrations of 1.9-3.2x108 copies of 16SrRNA gene/mL to steady 
concentrations of 2.2E+05 for SBR-5d, 7.6E+04 for SBR-10d, and 1.0E+04  copies/mL 
for SBR-20d of SRT.    
The gene copy numbers for strain ARI-1, AOB, and amoA genes in SBRs were 
also measured (Figure 6.5).  The 16SrRNA gene of strain ARI-1 was detected at low 
quantities in all three SBRs, ranging from 1.4E+00 to 1.4E+01 copies /mL.   These low 
values were expected since strain ARI-1 was not spiked during the startup of the 
bioreactors.  Ammonia oxidizing bacteria and amoA genes were detected in all three 
SBRs, ranging from  7.7E+03 to 3.6E+04 copies/mL, and  1.5E+02 to 3.7E+03 
copies/mL, respectively.  
 
 
 
 
 78
Figure 6.4A      
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Figure 6.4B 
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Figure 6.4  Quantification of total bacteria (16S rRNA) and strain KC8 in SBRs 
operating under 5d (Figure 6.4A), 10d (Figure 6.4B), and 20d (Figure 6.4C) of SRT. 
Microbial diversity indices in samples at steady state (at 3 x SRT) under each SRT 
condition were described in text boxes.  Open diamonds (total 16S rRNA) and solid 
squares (strain KC8).  Error bars indicate the standard deviation of the results of real-
time PCRs. 
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Figure 6.4C 
 
 
 
 
 
 
 
 
 
 
SBR-20d
1.00E+02
1.00E+04
1.00E+06
1.00E+08
1.00E+10
0 10 20 30 40 50 60 70
Day
# 
 c
op
ie
s/m
L
KC8
Total 16S
Day 0
1xSRT 2xSRT 3xSRT
S =12,        H' =2.386
E =0.665, 1/D =10.155
 
Figure 6.4  Continued. 
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(1) The values were measured for samples of SBRs at steady state under each SRT condition. 
(2) After operating three times of SRTs in each SRT conditions, MLVSS concentrations were 0.45,      
0.71, and 0.92 g/L for 5, 10, 20d of SRTs, respectively. 
 
Figure 6.5  Quantification of total bacteria (16S rRNA), estrogen degraders, and amoA 
gene in SBRs at steady state under three different SRT conditions.  SBR-5d (black), 
SBR-10d (open), and SBR-20d (upward diagonal).  Error bars indicate the standard 
deviation of results of real-time PCRs. 
 
6.2.5 Prevalence of Estrogen Degraders in Wastewater Treatment Plants 
The quantities of estrogen degraders and amoA gene in WWTP samples were 
quantified using real-time PCR assays.  Despite the differences in operating conditions 
and treatment process configurations among the WWTPs, the quantity of strain KC8 was 
not much different between 2.8E+04 and 2.8E+05 copies/mL.  However, much lower 
gene copies of strain ARI, ranging from 2.1E+02 to 6.3E+03 copies/mL, were observed 
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in all three WWTP samples.   The concentrations of AOB ranged from 7.6E+04 to 
3.7E+05 copies/mL.  The amoA gene copy numbers were measured from 1.5E+04 to 
2.1E+04 copies/mL (Table 6.3). 
 
Table 6.3  Quantification of estrogen degrading bacteria and amoA gene in WWTPs 
WWTP #3 
WWTPs WWTP #1 WWTP #2 
1st stage 2nd stage 
Total  bacteria 
(16S rRNA) 
7.98E+09 
(2.22E+09) 
1.43E+10 
(3.98E+09) 
1.72E+10 
(4.77E+09) 
Strain KC8 7.22E+04 (7.22E+04) 
2.84E+05 
(2.84E+05) 
2.78E+04 
(2.78E+04) 20-30 
ARI-1 6.34E+03 (6.34E+03) 
2.14E+02 
(2.14E+02) 
5.16E+02 
(5.16E+02) 1.10 
AOB 1.51E+05 (1.51E+05) 
1.93E+05 
(1.93E+05) 
7.42E+05 
(7.42E+05) 
Real-time 
PCR assay, 
#copies/mL 
(cells/mL) (1) 
amoA 1.68E+04 (8.38E+03) 
2.12E+04 
(8.38E+03) 
1.51E+04 
(7.57E+03) 
1) cells/mL  = (#copies/mL) / (gene copy number/cell). Gene copy number/cell is assumed to be 3.6 (total 
16S rRNA), 1.0 (strainKC8, ARI-1, and AOB), and 2 (amoA gene) (72) 
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6.3 Discussion 
 In this study, the effects of SRT (5, 10, and 20 d) on estrogen removal, TOC 
removal, and nitrification were investigated in three lab-scale SBRs. All SBRs reached 
pseudo-steady state conditions after operated for three times of SRT, based on the 
monitoring results of MLVSS, TOC, ammonia, nitrite, and nitrate (Figure 6.1). The three 
times of SRT are consistent with previous reports that it requires 1.5 to 5 times of SRT 
for bioreactors to reach steady state conditions (128, 134, 135).    The removals of TOC 
and ammonia in all three SBRs are also consistent with findings of previous studies on 
the performance of bioreactors operated under similar SRT conditions (136-139).   Long 
SRTs are required for effective nitrification because the key players, AOB and nitrite-
oxidizing bacteria, are slow growers.  Not surprisingly, a slightly higher ammonia 
removal was observed in SBR-20d.  Surprisingly, in this study, the high ammonia 
removal did not correspond to the decline ratios of AOB or amoA gene to total bacterial 
population as SRT increased (Figure 6.5).   To our knowledge, this trend was not 
expected nor reported previously.    On the other hand, results of samples from WWTPs 
are consistent with the results reported by Kuo et al that the ratios of AOB or amoA gene 
to total bacteria increased as SRT increased (73).  However, due to small sample 
numbers of WWTPs surveyed in this study, effects of SRT on AOB or amoA can not be 
established.  
 Similar declining trend was observed for the ratios of strain KC8 to total bacterial 
population when SRT increased from 5 d to 20 d.   The concentrations of strain KC8 
decreased more than 1000  times, from 1.9~3.2 x 108 to 1.0~22 x 104 gene copies/mL, 
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corresponding to a decline  ratio of strain KC8 to total bacterial population (KC8/total 
bacteria) from 0.27 % to 0.003 %.  The decline of strain KC8 concentration as SRT 
increased can be explained by the characteristics of strain KC8.  Based on our estrogen 
degradation and growth kinetics study (27), a minimum SRT of  12 d would be needed 
when strain KC8 uses 17β-estradiol as a sole carbon source.   Since strain KC8 can grow 
much faster when utilizes common organics (glucose, succinate, acetate) in wastewater, 
it is expected that strain KC8 can survive under a SRT as short as 5 d.  Not surprisingly, 
in this study, strain KC8 was detected in all three SBRs operated under 5 to 20 d.  The 
decline over SRT might be due to a high decay coefficient of estrogen degraders.   The 
concentrations of strain ARI-1 were much lower than the concentrations of AOB and 
strain KC8 in SBRs and three WWTPs, suggesting strain ARI-1 might not be important 
for estrogen removal in the bioreactors.   
Several studies reported that high estrogen removals in WWTPs operating under 
long SRTs (124, 127, 131, 132, 140).   However, no significant differences in estrogen 
removals (>98.7 %) were observed in three SBRs as shown in Figure 6.2.  In fact, our 
results of estrogen degraders (Figure 6.5) and the biodegraded percentages of 17β-
estradiol (Figure 6.2) suggested an opposite finding - biodegradation of estrogen was 
higher when SBR operated under a short SRT (5 d) than a long SRT (20 d). This finding 
is also supported by the declining trends of the ratios of strain KC8, AOB, and amoA 
genes, as discussed above.   However, it remains unclear which estrogen degraders, 
mainly AOB and strain KC8, were actively involved in 17β-estradiol degradation.  
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Based on real-time-t-RFLP profiles, more T-RFs were observed in SBR-20d than 
in SBR-5d and six ribotypes (T-RF = 84, 104, 106, 305, 326, and 328 bp) might coexist in 
three SBRs (Figure 6.3). The ranges of evenness (E) were not too big (0.64-0.67) in all 
three SBRs, implying no significant differences of variations in communities between the 
species.   The higher values of S, H, and 1/D were observed for SBR-20d (Table 6.2), 
suggesting that higher diversity of microbial community structure in SBR-20d than in 
SBR-5d.  These results are consistent with previous reports (127, 128) that longer SRT 
might lead to more diverse microbial community structure.   
However, as more than one species might contribute to one single T-RF, the 
diversity indices might change if different restriction enzyme (other than MspI) was used 
for real-time-t-RFLP analysis. This aspect was explored by Saikaly et al. (99).  In their 
study, they reported that diversity indices would depend on the types of restriction enzyme 
used and that higher degree of diversity might not correspond to higher SRT.   In this 
study, we further examined this aspect by conducting   an exercise of in-silico digestion 
with restriction enzyme MspI on known estrogen degraders.  As shown in Table 6.1, many 
known estrogen degraders would contribute to T-FRs= 84, 99,104, 106, and 187 bp.  
Accordingly, it will not be an easy task to determine the true diversity of a given microbial 
community without the knowledge on the identity of each microorganism and its 
abundance. 
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7. SUMMARY, CONCLUSIONS, AND FUTURE STUDIES 
 
7.1 Overview 
 Due to the potential adverse effects of environmental estrogens on the 
reproductive system of aquatic wildlife and humans, the effective estrogen removal by 
biodegradation in wastewater treatment plants is essential.  Several bacteria and 
activated sludge degrade estrogens.  This study is the first to examine the characteristics 
of estrogen degraders (strains KC6, KC7, and KC8) and the effects of an operating 
parameter (SRT) on estrogen removals and the microbial community structure in 
bioreactors. 
The overall hypothesis of this study, “Enhanced estrogen degradation can be 
achieved by promoting the growth of estrogen-degraders in engineered bioreactors”, was 
tested by the characterization of estrogen degraders (Sections 4 and 5) and the 
applications of estrogen degraders in bioreactors (Section 6). The results (Section 4) of 
growth tests exhibited that strain KC8 was capable of growing in the acetone-free NMS-
estrogen medium for two weeks, with an average growth yield of 0.23 mg of protein/mg 
of 17β-estradiol and a doubling time of 27 h; however, no significant growth of strains 
KC6 and KC7 was observed.  Since estrogens were degraded aerobically by strains KC6, 
KC7, and KC8, it was assumed that oxygenase enzymes have a key role in estrogen 
degradation.  Strain KC8 contains nonspecific monooxygenase enzyme activities. Strain 
KC8 can degrade and grow with 17β-estradiol and testosterone, suggesting that the 
degradation pathway for 17β-estradiol and testosterone in strain KC8 might be similar or 
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even the same. In this study, the enzymes responsible for estrogen degradation were 
unclear.  More studies are needed to elucidate the degradation pathway.    
The Monod kinetic parameters of estrogens and testosterone degradation by 
strain KC8 estimated in Section 5 were smaller than those for heterotrophs in activated 
sludge processes, implying that relatively longer solids retention time is needed in 
activated sludge processes to remove estrogens.  If strain KC8 can grow rapidly in other 
common organic compounds, the need for long SRT would be overcome.  This 
hypothesis was verified by examining for strain KC8’s ability to grow on glucose 
(representative carbohydrate in wastewater) and two major compounds in TCA cycle 
(sodium succinate and sodium acetate).  The range of doubling times for those 3 
compounds is small, suggesting that strain KC8 might be abundant in activated sludge 
systems. The hypothesis was tested by quantifying strain KC8 in bioreactors (Section 6).  
Since after having grown on nutrient-rich, estrogen-free medium for 7d, ARI-1 (a known 
estrogen degrader) lost its degradation ability toward estrone, a major metabolite of 17β-
estradiol in a previous study, strain KC8 was examined to see if it retained the ability to 
degrade 17β-estradiol and estrone after growth on complex nutrient containing no-
estrogen for 15 d.   
The effects of normal ranges of SRT (5, 10, and 20 d) on the estrogen removals 
and the changes of estrogen-degrading microbial community structures in lab-scale 
SBRs were investigated (Section 6).  Since strain KC8 utilized succinate as a growth 
substrate, synthetic wastewater containing succinate was added as a carbon source in 
bioreactor operations.  Total organic carbons and ammonia removals in SBRs were 
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consistent with the results of previous studies, and both removals under higher SRT (20 
d) are slightly higher than those under shorter SRTs (5 and 10 d).  Effective removals 
(>98.7 %) of 17β-estradiol with no significant differences were observed in SBRs under 
three SRTs.  The biodegraded percentages of 17β-estradiol were higher when SBR 
operated under a short SRT (5 d) than a long SRT (20 d). This finding was supported by 
the declining trends of the ratios of strain KC8, AOB, and amoA genes to total bacteria 
as SRT increased in SBRs.  However, it remains unclear which estrogen degraders were 
actively involved in 17β-estradiol degradation. The microbial diversity based on the 
variations of solids retention time and other parameters in activated sludge processes 
was analyzed by real-time-t-RFLP assay. There were 9, 10, and 12 ribotypes in samples 
of 5, 10, and 20 d of SRTs at steady state in SBRs, respectively.  Some of those 
ribotypes might be contributed by known estrogen degraders including strain KC8, AOB, 
and ARI-1.  The higher richness in SBR at the longer SRT (20 d) indicated that the 
microbial community structure is more diverse than those in SBRs at 5 and 10 d of SRT.  
The values of diversity indices imply that the operating parameter of SRT might be an 
important factor to diversify microbial community structure. 
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7.2 Summary and Conclusions 
1) Strain KC8 could utilize 17β-estradiol as a growth substrate. The average growth 
yield was estimated to be 0.23 mg-protein/mg-17β-estradiol, and the doubling time 
was 27h.  However, no significant degradation of 17β-estradiol or no cell growth 
were observed for strains KC6 and KC7, suggesting that strains KC6 and KC7 could 
not utilize 17β-estradiol as a growth substrate.  It is likely that the degradation of 
17β-estradiol by strain KC8 is growth-linked (metabolic) reactions, while the 17β-
estradiol degradations by strains KC6 and KC7 might be due to nongrowth-linked 
(cometabolic) reactions.   
2) Strain KC6, KC7, and KC8 exhibited nonspecific monooxygenase enzyme activity, 
but not nonspecific dioxygenase enzyme activity.  
3) Strain KC8 could degrade testosterone as a growth substrate, but not triclosan or 
bisphenol A.  The average growth yield was estimated to be 0.33 mg-protein/mg- 
testosterone, and the doubling time was 61 h.  Strain KC8 was able to utilize organic 
substrates (glucose, succinate, and acetate) for its growth, except for phenol. the 
average cellular yields were estimated to range from 0.04 to 0.4 mg-VSS/mg-BODL.  
The doubling time was estimated to range from 20 to 29 h when different substrates 
were used, which suggests that strain KC8 is very likely thrive in activated sludge 
systems. 
4)  The Monod equation described estrogens and testosterone degradation kinetics well. 
The maximum specific substrate utilization rate ( ) were estimated to be 0.37 ± 
0.02, 0.50 ± 0.02, and 0.17 ± 0.01 mg-substrate/mg-protein/d and the estimated half 
mq
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velocity constants ( ) are 1.9 ± 0.2, 2.7 ± 0.3, and 2.4 ± 0.4 mg-substrate/L for 
17β-estradiol, estrone, and testosterone.  
mK
5)  Strain KC8 retained its ability to degrade 17β-estradiol and estrone after growth on 
complex nutrients without 17β-estradiol for 15 d, unlike another estrogen degrader, 
ARI-1.  These results imply that strain KC8 would play an important role on 
degrading estrogen into non-estrogenic metabolites/end product even in wastewater 
with low, and/or fluctuating concentrations of estrogens. 
6)  TOC removals were 87, 89, and 92 % under 5, 10, and 20 d of SRTs, respectively. 
The ranges of ammonia removals in SBRs were 91-99 % for 5 d, 96-99 % for 10 d, 
and 97-99 % for 20 d of SRT.  The higher ammonia removals at long SRT (20 d) 
were consistent with the information that long SRTs are required since the key 
players (AOB and nitrite-oxidizing bacteria) for nitrification, are slow growers. 
Surprisingly, in this study, the high ammonia removal did not correspond to the 
decline ratios of AOB or amoA gene to total bacterial population as SRT increased. 
7)  Regardless of SRTs (5, 10, or 20 d), similar overall removals of total organic content 
(TOC, >87 %), ammonia (>91 %) and 17β-estradiol (> 98.7 %) in SBRs were 
observed.  The ratios of known estrogen degraders (strains KC8 and ammonia-
oxidizing bacteria (AOB) and amoA gene (associated with ammonia oxidation) to 
total bacteria population decreased as SRT increased in SBRs.  These observations 
correspond to the decreasing percentages of 17β-estradiol biodegraded in SBR when 
SRT increased from 5 d to 20 d, when the sorption of 17β-estradiol onto biomass 
was considered. 
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8)  Base on real-time-t-RFLP (using the restriction enzyme MspI), more ribotypes were 
observed in SBRs operated under 20 d than 5 d.  The species evenness (E) in 
microbial community structures in three SBRs was not affected by SRT.  However, 
diversity indices (Shannon-Weaver diversity index (H) and the reciprocal of 
Simpson’s index (1/D)) suggested that longer SRT might lead to more diverse 
microbial community structure.  
 
7.3 Future Studies 
1)   This study reported that nonspecific monooxygenase enzyme activities are present in 
strains KC6, KC7, and KC8; however, the roles of the enzymes in estrogen 
degradation pathway are still unclear. More studies are needed to describe the roles 
of the enzymes in the degradation pathway and to identify any metabolites of 
estrogen degradation by strain KC8.  These efforts will help to propose a degradation 
pathway of estrogens. 
2)  The effects of solids retention times on estrogen removals and microbial community 
structures in lab-scale bioreactors were studied in this study.  Additional 
optimization studies are needed for enhancing estrogen removals in bioreactors. The 
operation parameters (dissolved oxygen concentrations, carbon/nitrogen ratios, 
temperatures, and pH) can be optimized for estrogen removals in wastewater 
treatment processes. 
3)  The application studies of molecular technologies (real-time PCR and real-time-t-
RFLP) in various WWTPs using different operating parameters as well as the fate of 
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estrogens in the plants are necessary to better understand the relationships between 
microbial community structures or the prevalence of estrogen degraders and their 
operating conditions. 
4)  The estrogenic activity needs to be measured with samples of SBRs by using an 
estrogenic activity assay even though estrogen appeared to be removed in SBRs. 
5)  The correlations between the population of estrogen degraders and the estrogen 
degradation need to be investigated in the future.  In addition, further investigations 
about which estrogen degraders in mixed culture are more actively involved in 
estrogen degradation will be necessary.   
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APPENDIX A   
VALIDATION OF REAL-TIME PCR ASSAYS 
 
A-1. Validation of Real-time PCR Assay for Strain KC8 
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Linear range of template concentrations for real-time PCR assays specific for strain KC8. 
Total DNA extracted from strain KC8 (solid diamonds); total DNA extracted from 
mixed strain KC8 and activated sludge samples collected from SBR bioreactor (open 
circles).  Equations of the regressions are as follows: y= 31.78 - 3.86x, r2 = 0.999 
(mixture); y= 20–3.67x, r2 = 0.998 (strain KC8). Error bars indicate the range of 
duplicate real-time PCRs. CT, threshold cycle. 
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A-2. Validation of Real-time PCR Assay for Strain ARI-1 
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Linear range of template concentrations for real-time PCR assays specific for strain 
ARI-1. Total DNA extracted from ARI-1 (solid circles); total DNA extracted from 
mixed strain KC8 and activated sludge samples (open circles).  Equations of the 
regressions are as follows: y= 33.50–1.42x, r2 = 0.993 (mixture); y= 24.83 – 1.49x, r2 = 
0.994 (ARI-1) (S2).  Error bars indicate the range of duplicate real-time PCRs. CT, 
threshold cycle. 
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APPENDIX B 
REMOVAL OF 17β-ESTRADIOL IN SBRs 
 
B-1. Total Mass of 17β-Estradiol and Percentage Removal in SBRs under 5, 10, and 20d  
of SRTs 
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  *  17β-estradiol removals 
 
Total mass of 17β-estradiol added and removed of each cycle (24 hr) in SBR-5d, SBR-
10, and SBR-20d.  Steady state data (i.e. after 2 times of SRT) was used for calculation.  
Average removal of 17β-estradiol for each SBR was listed in the parenthesis.  Influent 
mass of 17β-estradiol (upward diagonal) and effluent mass of 17β-estradiol (black). 
Error bars indicate the standard deviation of 17β-estradiol removals, based on 5, 10, and 
20 data points for SBR-5d, SBR-10, and SBR-20d, respectively.  Influent mass of 17β-
estradiol (upward diagonal) and effluent mass of 17β-estradiol (black). Error bars 
indicate the standard deviation of results of 17β-estradiol removals. 
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B-2. Sample Calculation of Mass Balance of 17β-estradiol after 3xSRT in SBRs  
 Operating after 3xSRT 
 
Description* Day 15  at SBR-5d 
Day 30  
at SBR-10d 
Day 60  
at SBR-20d 
Massin  (ng/d) 1,0x106 1,0x106 1,0x106 
Massout  (ng/d) 5.7x103 9.9x103 1.4x104 
Px** 
(Sludge production,mg-sludge 
produced /L-treated wastewater
18.9 17.0 16.9 
Removal (%) 99.5 99.1 98.7 
*   The equations (eq 1-2, 4-5) in Pholchan et. al. (140) were used for these calculations.  
** inf inf
( ) ( )( ) ( )1
1 ( ) 1 ( )
eff d d eff
X
d d
QY COD COD f k QY COD COD SRT
P
Q k SRT k SRT
− −⎡ ⎤= +⎢ ⎥+ +⎣ ⎦
 
      where,  Q: influent flow (L/d),   Y:heterotrophic biomass yield 
  CODinf  and CODeff : influent and effluent COD (mg/L) 
  kd : heterotrophic endogenous decay coefficient ( 0.12gVSS/gVSS-d) 
  fd : cell debris fraction (=0.15)   
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